1,780 results on '"Tyrosine Transaminase"'
Search Results
2. Phenylalanine suppresses cell death caused by loss of fumarylacetoacetate hydrolase in Arabidopsis
- Author
-
Yihe Jiang, Qi Zhu, Hua Yang, Tiantian Zhi, and Chunmei Ren
- Subjects
Chlorophyll ,Ammonia-Lyases ,Multidisciplinary ,Cell Death ,Hydrolases ,Phenylalanine ,Arabidopsis ,Animals ,Tyrosine ,Tyrosine Transaminase - Abstract
Fumarylacetoacetate hydrolase (FAH) catalyzes the final step of Tyrosine (Tyr) degradation pathway essential to animals and the deficiency of FAH causes an inborn lethal disease. In plants, a role of this pathway was unknown until we found that mutation of Short-day Sensitive Cell Death1 (SSCD1), encoding Arabidopsis FAH, results in cell death under short day. Phenylalanine (Phe) could be converted to Tyr and then degraded in both animals and plants. Phe ingestion in animals worsens the disease caused by FAH defect. However, in this study we found that Phe represses cell death caused by FAH defect in plants. Phe treatment promoted chlorophyll biosynthesis and suppressed the up‑regulation of reactive oxygen species marker genes in the sscd1 mutant. Furthermore, the repression of sscd1 cell death by Phe could be reduced by α-aminooxi-β-phenylpropionic acid but increased by methyl jasmonate, which inhibits or activates Phe ammonia-lyase catalyzing the first step of phenylpropanoid pathway, respectively. In addition, we found that jasmonate signaling up‑regulates Phe ammonia-lyase 1 and mediates the methyl jasmonate enhanced repression of sscd1 cell death by Phe. These results uncovered the relation between chlorophyll biosynthesis, phenylpropanoid pathway and jasmonate signaling in regulating the cell death resulting from loss of FAH in plants.
- Published
- 2022
3. Downregulation of the tyrosine degradation pathway extends
- Author
-
Andrey A, Parkhitko, Divya, Ramesh, Lin, Wang, Dmitry, Leshchiner, Elizabeth, Filine, Richard, Binari, Abby L, Olsen, John M, Asara, Valentin, Cracan, Joshua D, Rabinowitz, Axel, Brockmann, and Norbert, Perrimon
- Subjects
Aging ,D. melanogaster ,fungi ,Longevity ,Genetics and Genomics ,Tigecycline ,neurotransmitters ,Mitochondria ,ETC Complex I ,Drosophila melanogaster ,Electron Transport Chain Complex Proteins ,Animals ,Tyrosine ,tyrosine aminotransferase ,TAT ,Tyrosine Transaminase ,Research Article - Abstract
Aging is characterized by extensive metabolic reprogramming. To identify metabolic pathways associated with aging, we analyzed age-dependent changes in the metabolomes of long-lived Drosophila melanogaster. Among the metabolites that changed, levels of tyrosine were increased with age in long-lived flies. We demonstrate that the levels of enzymes in the tyrosine degradation pathway increase with age in wild-type flies. Whole-body and neuronal-specific downregulation of enzymes in the tyrosine degradation pathway significantly extends Drosophila lifespan, causes alterations of metabolites associated with increased lifespan, and upregulates the levels of tyrosine-derived neuromediators. Moreover, feeding wild-type flies with tyrosine increased their lifespan. Mechanistically, we show that suppression of ETC complex I drives the upregulation of enzymes in the tyrosine degradation pathway, an effect that can be rescued by tigecycline, an FDA-approved drug that specifically suppresses mitochondrial translation. In addition, tyrosine supplementation partially rescued lifespan of flies with ETC complex I suppression. Altogether, our study highlights the tyrosine degradation pathway as a regulator of longevity.
- Published
- 2020
4. Effects Mifepristone on Aminotransferase Activities in the Liver in Rats with Streptozotocin-Induced Diabetes Mellitus
- Author
-
O. I. Kuzminova, N. A. Palchikova, K. V. Pasechnaya, and V. G. Selyatitskaya
- Subjects
Blood Glucose ,Male ,medicine.medical_specialty ,030209 endocrinology & metabolism ,digestive system ,General Biochemistry, Genetics and Molecular Biology ,Diabetes Mellitus, Experimental ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Tyrosine aminotransferase ,Corticosterone ,Diabetes mellitus ,Internal medicine ,medicine ,Animals ,Aspartate Aminotransferases ,Rats, Wistar ,Glucocorticoid hormones ,Glucocorticoids ,Tyrosine Transaminase ,business.industry ,Alanine Transaminase ,General Medicine ,Mifepristone ,Streptozotocin ,medicine.disease ,digestive system diseases ,Rats ,Receptor blockade ,Endocrinology ,Liver ,chemistry ,business ,030217 neurology & neurosurgery ,Glucocorticoid ,medicine.drug - Abstract
The glucocorticoid status and activities of ALT, AST, and tyrosine aminotransferase in the liver are studied in rats with streptozotocin-induced diabetes mellitus in response to repeated intraperitoneal injections of mifepristone. Diabetic rats develop an increase of the blood corticosterone and liver aminotransferase levels in response to mifepristone. These results indicate that in diabetic animals the glucocorticoid hormones with high blood concentrations, increasing still more in response to mifepristone, overcome the receptor blockade, and realize their regulatory functions in hepatocytes. The effects of mifepristone on ALT activity are the most manifest. In normal rats, only ALT activity is increasing in response to mifepristone, while in rats with streptozotocin-induced diabetes mellitus, ALT activity increases more intensely than activities of tyrosine aminotransferase and AST.
- Published
- 2018
5. Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver
- Author
-
Vivaswath S. Ayyar, Jun Qu, Siddharth Sukumaran, William J. Jusko, Richard R. Almon, and Debra C. DuBois
- Subjects
Male ,Proteomics ,0301 basic medicine ,Transcription, Genetic ,Cell ,Apoptosis ,Pharmacology ,Methylprednisolone ,Models, Biological ,030226 pharmacology & pharmacy ,Article ,03 medical and health sciences ,Receptors, Glucocorticoid ,0302 clinical medicine ,Tyrosine aminotransferase ,Immune system ,Adrenal Cortex Hormones ,medicine ,Animals ,Insulin ,Glucose homeostasis ,RNA, Messenger ,RNA Processing, Post-Transcriptional ,Rats, Wistar ,Receptor ,Glucocorticoids ,Tyrosine Transaminase ,Messenger RNA ,Chemistry ,Acute-phase protein ,Rats ,030104 developmental biology ,medicine.anatomical_structure ,Liver ,Transcriptome ,Signal Transduction - Abstract
A multiscale pharmacodynamic model was developed to characterize the receptor-mediated, transcriptomic, and proteomic determinants of corticosteroid (CS) effects on clinically relevant hepatic processes following a single dose of methylprednisolone (MPL) given to adrenalectomized (ADX) rats. The enhancement of tyrosine aminotransferase (TAT) mRNA, protein, and enzyme activity were simultaneously described. Mechanisms related to the effects of MPL on glucose homeostasis, including the regulation of CCAAT-enhancer binding protein-beta (C/EBPβ) and phosphoenolpyruvate carboxykinase (PEPCK) as well as insulin dynamics were evaluated. The MPL-induced suppression of circulating lymphocytes was modeled by coupling its effect on cell trafficking with pharmacogenomic effects on cell apoptosis via the hepatic (STAT3-regulated) acute phase response. Transcriptomic and proteomic time-course profiles measured in steroid-treated rat liver were utilized to model the dynamics of mechanistically relevant gene products, which were linked to associated systemic end-points. While time-courses of TAT mRNA, protein, and activity were well described by transcription-mediated changes, additional post-transcriptional processes were included to explain the lack of correlation between PEPCK mRNA and protein. The immune response model quantitatively discerned the relative roles of cell trafficking versus gene-mediated lymphocyte apoptosis by MPL. This systems pharmacodynamic model provides insights into the contributions of selected molecular events occurring in liver and explores mechanistic hypotheses for the multi-factorial control of clinically relevant pharmacodynamic outcomes.
- Published
- 2018
6. Characteristics, tissue-specific expression, and hormonal regulation of expression of tyrosine aminotransferase in the avian female reproductive tract
- Author
-
Gwonhwa Song and Whasun Lim
- Subjects
0301 basic medicine ,Aging ,medicine.medical_specialty ,animal structures ,medicine.drug_class ,viruses ,Ovary ,Oviducts ,Molting ,Biology ,Gene Expression Regulation, Enzymologic ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Tyrosine aminotransferase ,Food Animals ,Internal medicine ,microRNA ,medicine ,Animals ,Tissue Distribution ,Amino Acid Sequence ,Tyrosine ,Gene ,Tyrosine Transaminase ,Messenger RNA ,Estrogens ,MicroRNAs ,030104 developmental biology ,medicine.anatomical_structure ,Estrogen ,030220 oncology & carcinogenesis ,Oviduct ,Female ,Animal Science and Zoology ,Chickens - Abstract
Tyrosine aminotransferase (TAT) catalyzes the transamination of tyrosine to p-hydroxyphenylpyruvate. Accumulation of tyrosine in the body due to a genetic mutation in the TAT gene causes tyrosomia type II in humans. The TAT gene is regarded as a model for studying steroid-inducible factors regulating a variety of biological functions of TAT. However, little is known of the effects of estrogen on the expression of the TAT gene in chickens. Therefore, in the present study, we identified expression of the avian TAT gene in various organs. The results showed the TAT was detected predominantly in the liver and reproductive organs including testis, oviduct, and ovary. Specifically, TAT mRNA was expressed abundantly in the glandular and luminal epithelia of the oviducts in response to endogenous and exogenous estrogens which also induce dramatic morphological changes in the oviduct of chickens. In addition, target microRNAs of TAT (miR-1460, miR-1626-3p, miR-1690-5p, and miR-7442-3p) were found to modulate expression of the TAT gene. Especially, miR-1690-5p influenced TAT gene transcription by binding directly to its 3'-UTR region. Moreover, the expression of TAT was abundant in glandular epithelia of cancerous but not normal ovaries from laying hens. Taken together, our findings suggest that TAT plays an important role in the cytodifferentiation of oviducts in response to estrogen and in the progression of ovarian cancer in chickens.
- Published
- 2016
7. Purification, characterization and identification of rat brain cytosolic tyrosine transaminase as glutamine Transaminase-K
- Author
-
David P. Henry and Ronald R. Bowsher
- Subjects
0301 basic medicine ,Transamination ,Glutamine ,Tyrosine Transaminase ,Glyoxylate cycle ,Transaminase ,Substrate Specificity ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,chemistry.chemical_compound ,0302 clinical medicine ,Cytosol ,Aromatic amino acids ,Animals ,Tyrosine ,Rats, Wistar ,Transaminases ,chemistry.chemical_classification ,Chemistry ,Brain ,Cell Biology ,Keto Acids ,Amino acid ,030104 developmental biology ,Biochemistry ,030217 neurology & neurosurgery - Abstract
The current study was undertaken to investigate the spectrum of tyrosine transaminases enzymes in a cytosolic fraction of rat brain and to specifically purify and characterize a previously identified cytosolic brain enzyme possessing tyrosine/glyoxylate transaminase activity. Based upon extensive biochemical and immunochemical characterization of purified brain tyrosine/glyoxylate transaminase, we concluded the purified enzyme is glutamine transaminase-K (EC 2.6.1.64). This conclusion was based on: 1.) a concurrent enrichment in the tyrosine/glyoxylate and glutamine/phenylpyruvate transaminase activities during purification, 2.) demonstration of a co-substrate specificity for amino acids and α-keto acids that was highly consistent with published information for glutamine transaminase-K, 3.) results from detailed kinetic analysis, 4.) glutamine was a potent inhibitor of in vitro tyrosine/glyoxylate transamination, 5.) biochemical characterization, including pH optimum of 8.5 and spectrophotometric analysis and 6.) immunoanalytical analysis using a specific antiserum to rat renal glutamine transaminase-k. In addition, immunochemical characterization of a crude soluble extract of whole brain suggests that the in vitro tyrosine transaminase activity for several different α-keto acid co-substrates likely reflect the activity of glutamine transaminase-K. In conclusion, this investigation confirmed the presence of multiple tyrosine transaminase enzymes in a cytosolic extract of rat brain. Moreover, we concluded glutamine transaminase-K represents a predominant cytosolic enzyme in rat brain that's capable of catalyzing in vitro transamination of p-tyrosine and other aromatic amino acids, including the neurotransmitter precursors L-dopa and 5-hydroxytryptophan. The purified transaminase possesses a broad co-substrate specificity with preferential reactivity with α-keto acids derived from neutral aliphatic and aromatic amino acids. Lastly, we identified a heterogeneous regional distribution of tyrosine/glyoxylate transaminase (glutamine transaminase-K) in rat brain with a significantly higher level of in vitro activity in cerebellum.
- Published
- 2019
8. Epigenetic Modulators Enhance Constitutive and Liver-Specific Reporter Expression in Murine Liver Progenitor Cell Lines
- Author
-
Sarah B. McSpadden, George C.T. Yeoh, Michel Elyse Watson, Robyn P. Strauss, Bernard A. Callus, and Luke A. Diepeveen
- Subjects
Liver cytology ,Cellular differentiation ,Transgene ,Cell ,Biomedical Engineering ,Medicine (miscellaneous) ,Bioengineering ,Biology ,Cell Line ,Epigenesis, Genetic ,Mice ,chemistry.chemical_compound ,Genes, Reporter ,medicine ,Animals ,Progenitor cell ,Tyrosine Transaminase ,Stem Cells ,Cell Differentiation ,Sodium butyrate ,medicine.anatomical_structure ,Liver ,chemistry ,Organ Specificity ,Cell culture ,Hepatocytes ,Cancer research ,Stem cell - Abstract
Stem cells expressing reporter constructs are extremely useful for their tracking in vivo or for determining cell lineage fate in vivo and in vitro. We generated liver progenitor cell (LPC) lines from actin-EGFP and TAT-GRE-lacZ mice. LPCs from the actin-EGFP mouse facilitate cell tracing following transplant as the reporter is constitutively expressed. LPCs from the TAT-GRE-lacZ mouse express β-galactosidase under the control of the tyrosine aminotransferase (TAT) promoter and are only active in mature hepatocytes. We found that the utility of such LPC lines becomes severely limited by downregulation of transgene expression following extended culture. We show that epigenetic mechanisms are responsible for suppressing expression of both transgenes. Enhancement of transgene expression in both LPC lines was achieved by treating the cell lines with either the histone acetylating agent sodium butyrate or the DNA demethylating agent 5-azacytidine.
- Published
- 2015
9. Tyrosine aminotransferase is involved in the oxidative stress response by metabolizing
- Author
-
Brett R, Ipson, Rebecca A, Green, John T, Wilson, Jacob N, Watson, Kym F, Faull, and Alfred L, Fisher
- Subjects
DNA-Binding Proteins ,Oxidative Stress ,Metabolism ,Gene Expression Regulation ,Longevity ,Mutation ,Animals ,Tyrosine ,Caenorhabditis elegans ,Caenorhabditis elegans Proteins ,Oxidation-Reduction ,Transcription Factors ,Tyrosine Transaminase - Abstract
Under oxidative stress conditions, hydroxyl radicals can oxidize the phenyl ring of phenylalanine, producing the abnormal tyrosine isomer meta-tyrosine (m-tyrosine). m-Tyrosine levels are commonly used as a biomarker of oxidative stress, and its accumulation has recently been reported to adversely affect cells, suggesting a direct role for m-tyrosine in oxidative stress effects. We found that the Caenorhabditis elegans ortholog of tyrosine aminotransferase (TATN-1)—the first enzyme involved in the metabolic degradation of tyrosine—is up-regulated in response to oxidative stress and directly activated by the oxidative stress–responsive transcription factor SKN-1. Worms deficient in tyrosine aminotransferase activity displayed increased sensitivity to multiple sources of oxidative stress. Biochemical assays revealed that m-tyrosine is a substrate for TATN-1–mediated deamination, suggesting that TATN-1 also metabolizes m-tyrosine. Consistent with a toxic effect of m-tyrosine and a protective function of TATN-1, tatn-1 mutant worms exhibited delayed development, marked reduction in fertility, and shortened lifespan when exposed to m-tyrosine. A forward genetic screen identified a mutation in the previously uncharacterized gene F01D4.5—homologous with human transcription factor 20 (TCF20) and retinoic acid–induced 1 (RAI1)—that suppresses the adverse phenotypes observed in m-tyrosine–treated tatn-1 mutant worms. RNA-Seq analysis of F01D4.5 mutant worms disclosed a significant reduction in the expression of specific isoforms of genes encoding ribosomal proteins, suggesting that alterations in protein synthesis or ribosome structure could diminish the adverse effects of m-tyrosine. Our findings uncover a critical role for tyrosine aminotransferase in the oxidative stress response via m-tyrosine metabolism.
- Published
- 2018
10. Hepatic SRC-1 Activity Orchestrates Transcriptional Circuitries of Amino Acid Pathways with Potential Relevance for Human Metabolic Pathogenesis
- Author
-
Lee-Jun C. Wong, Robert Stevens, Hui Yu, Ke Tang, Brian York, Christopher B. Newgard, Suoling Zhou, Mounia Tannour-Louet, Jianming Xu, Jean-Francois Louet, Hichem Bouguerra, Bert W. O'Malley, and Erin Stashi
- Subjects
medicine.medical_specialty ,Transcription, Genetic ,Biology ,Tyrosinemia ,Mice ,Nuclear Receptor Coactivator 1 ,Endocrinology ,Tyrosine aminotransferase ,Internal medicine ,Coactivator ,medicine ,Animals ,Amino Acids ,Tyrosine ,Amino Acid Metabolism, Inborn Errors ,Molecular Biology ,Original Research ,Tyrosine Transaminase ,Mice, Knockout ,chemistry.chemical_classification ,General Medicine ,Metabolism ,medicine.disease ,Cell biology ,Amino acid ,Nuclear receptor coactivator 1 ,Disease Models, Animal ,Liver ,chemistry ,Proto-oncogene tyrosine-protein kinase Src - Abstract
Disturbances in amino acid metabolism are increasingly recognized as being associated with, and serving as prognostic markers for chronic human diseases, such as cancer or type 2 diabetes. In the current study, a quantitative metabolomics profiling strategy revealed global impairment in amino acid metabolism in mice deleted for the transcriptional coactivator steroid receptor coactivator (SRC)-1. Aberrations were hepatic in origin, because selective reexpression of SRC-1 in the liver of SRC-1 null mice largely restored amino acids concentrations to normal levels. Cistromic analysis of SRC-1 binding sites in hepatic tissues confirmed a prominent influence of this coregulator on transcriptional programs regulating amino acid metabolism. More specifically, SRC-1 markedly impacted tyrosine levels and was found to regulate the transcriptional activity of the tyrosine aminotransferase (TAT) gene, which encodes the rate-limiting enzyme of tyrosine catabolism. Consequently, SRC-1 null mice displayed low TAT expression and presented with hypertyrosinemia and corneal alterations, 2 clinical features observed in the human syndrome of TAT deficiency. A heterozygous missense variant of SRC-1 (p.P1272S) that is known to alter its coactivation potential, was found in patients harboring idiopathic tyrosinemia-like disorders and may therefore represent one risk factor for their clinical symptoms. Hence, we reinforce the concept that SRC-1 is a central factor in the fine orchestration of multiple pathways of intermediary metabolism, suggesting it as a potential therapeutic target that may be exploitable in human metabolic diseases and cancer.
- Published
- 2014
11. JTP-117968, a novel selective glucocorticoid receptor modulator, exhibits improved transrepression/transactivation dissociation
- Author
-
Takashi Nakagawa, Atsuko Miyai, Takayuki Yamaguchi, Yuki Bessho, Katsuya Deai, Takahiro Hata, Yoshinori Kosugi, Mutsuyoshi Matsushita, Takafumi Kurimoto, Isao Tamai, Shohei Misaki, Yasuo Yamamoto, and Tamotsu Negoro
- Subjects
0301 basic medicine ,Transcriptional Activation ,medicine.medical_specialty ,Aminopyridines ,Pharmacology ,Non steroidal ,03 medical and health sciences ,chemistry.chemical_compound ,Transactivation ,Mice ,Glucocorticoid receptor ,Receptors, Glucocorticoid ,In vivo ,Internal medicine ,medicine ,Fosdagrocorat ,Animals ,RNA, Messenger ,Transrepression ,Tyrosine Transaminase ,Mice, Inbred BALB C ,Trifluoromethyl ,In vitro toxicology ,Phenanthrenes ,030104 developmental biology ,Endocrinology ,chemistry ,Hepatocytes ,Female ,Phenanthrolines - Abstract
Classic glucocorticoids that have outstanding anti-inflammatory effects are still widely prescribed for the treatment of various inflammatory and autoimmune diseases. Conversely, glucocorticoids cause numerous unwanted side effects, particularly systemically dosed glucocorticoids. Therefore, selective glucocorticoid receptor modulator (SGRM), which maintains beneficial anti-inflammatory effects while reducing the occurrence of side effects, is one of the most anticipated drugs. However, there have been no SGRMs marketed to date. The assumption is that there are two major mechanisms of action of glucocorticoids via glucocorticoid receptors, transrepression (TR) and transactivation (TA). In general, the anti-inflammatory effects of glucocorticoids are mostly mediated through TR, while the side effects associated with glucocorticoids are largely caused by TA. We started to evaluate novel orally available SGRMs that maintain anti-inflammatory effects while minimizing adverse effects by favoring TR over TA. Based on this evaluation, we discovered JTP-117968, (4b'S,7'R,8a'S)-4b'-benzyl-7'-hydroxy-N-(2-methylpyridin-3-yl)-7'-(trifluoromethyl)-4b',6',7',8',8a',10'-hexahydro-5'H-spiro[cyclopropane-1,9'-phenanthrene]-2'-carboxamide, a non-steroidal SGRM. JTP-117968 has partial TR activity, but exhibits extremely low TA activity. The maximum TR efficacy of JTP-117968 was comparable to its structural analogue, PF-802, (4bS,7R,8aR)-4b-Benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxamide, which is the active form of Fosdagrocorat that has been developed clinically as a first-in-class orally available SGRM. Remarkably, the TA activity of JTP-117968 was much weaker than PF-802 not only in in vitro assays, but also in in vivo mice experiments. These findings indicate that JTP-117968 exhibits improved TR/TA dissociation because the compound has significantly lower TA activity compared with an already reported SGRM. Therefore, JTP-117968 is expected to be a useful compound for evaluating ideal SGRMs in the future.
- Published
- 2016
12. l-Tyrosine Induces DNA Damage in Brain and Blood of Rats
- Author
-
Gustavo C. Ferreira, Gabriela D. Borges, Samira Dal-Toé De Prá, Daniela Dimer Leffa, Gabriela Elibio Fagundes, Júlia S. Vieira, Gabriela K. Ferreira, Milena Carvalho-Silva, Giselli Scaini, Bruno N. Bristot, Emilio L. Streck, Vanessa Moraes de Andrade, and Patrícia F. Schuck
- Subjects
medicine.medical_specialty ,DNA damage ,Biology ,medicine.disease_cause ,Biochemistry ,Tyrosinemia ,Cellular and Molecular Neuroscience ,Tyrosine aminotransferase ,Internal medicine ,medicine ,Animals ,Rats, Wistar ,Tyrosine Transaminase ,Tyrosinemia type II ,Tyrosinemias ,Metabolic disorder ,Brain ,General Medicine ,medicine.disease ,Pathophysiology ,Rats ,Comet assay ,Oxidative Stress ,Endocrinology ,Tyrosine ,Comet Assay ,Oxidative stress ,DNA Damage - Abstract
Mutations in the tyrosine aminotransferase gene have been identified to cause tyrosinemia type II which is inherited in an autosomal recessive manner. Studies have demonstrated that an excessive production of ROS can lead to reactions with macromolecules, such as DNA, lipids, and proteins. Considering that the L-tyrosine may promote oxidative stress, the main objective of this study was to investigate the in vivo effects of L-tyrosine on DNA damage determined by the alkaline comet assay, in brain and blood of rats. In our acute protocol, Wistar rats (30 days old) were killed 1 h after a single intraperitoneal L-tyrosine injection (500 mg/kg) or saline. For chronic administration, the animals received two subcutaneous injections of L-tyrosine (500 mg/kg, 12-h intervals) or saline administered for 24 days starting at postnatal day (PD) 7 (last injection at PD 31), 12 h after the last injection, the animals were killed by decapitation. We observed that acute administration of L-tyrosine increased DNA damage frequency and damage index in cerebral cortex and blood when compared to control group. Moreover, we observed that chronic administration of L-tyrosine increased DNA damage frequency and damage index in hippocampus, striatum, cerebral cortex and blood when compared to control group. In conclusion, the present work demonstrated that DNA damage can be encountered in brain from animal models of hypertyrosinemia, DNA alterations may represent a further means to explain neurological dysfunction in this inherited metabolic disorder and to reinforce the role of oxidative stress in the pathophysiology of tyrosinemia type II.
- Published
- 2013
13. Tyrosine Detoxification Is an Essential Trait in the Life History of Blood-Feeding Arthropods
- Author
-
Rodrigo Dutra Nunes, Marcos Sterkel, Marcos Henrique Ferreira Sorgine, Melina Garcia Guizzo, Felipe A. Dias, Pedro L. Oliveira, Ana Beatriz F. Barletta, and Hugo D. Perdomo
- Subjects
0301 basic medicine ,Male ,Nymph ,Nitisinone ,Rhodnius ,Tyrosine Transaminase ,4-Hydroxyphenylpyruvate Dioxygenase ,General Biochemistry, Genetics and Molecular Biology ,Mesotrione ,Microbiology ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Tyrosine aminotransferase ,medicine ,Animals ,Gene Silencing ,Tyrosine ,Rhodnius prolixus ,biology ,biology.organism_classification ,030104 developmental biology ,chemistry ,Biochemistry ,Inactivation, Metabolic ,Insect Proteins ,Female ,General Agricultural and Biological Sciences ,030217 neurology & neurosurgery ,4-Hydroxyphenylpyruvate dioxygenase ,medicine.drug - Abstract
Blood-feeding arthropods are vectors of infectious diseases such as dengue, Zika, Chagas disease, and malaria [1], and vector control is essential to limiting disease spread. Because these arthropods ingest very large amounts of blood, a protein-rich meal, huge amounts of amino acids are produced during digestion. Previous work on Rhodnius prolixus, a vector of Chagas disease, showed that, among all amino acids, only tyrosine degradation enzymes were overexpressed in the midgut compared to other tissues [2]. Here we demonstrate that tyrosine detoxification is an essential trait in the life history of blood-sucking arthropods. We found that silencing Rhodnius tyrosine aminotransferase (TAT) and 4-hydroxyphenylpyruvate dioxygenase (HPPD), the first two enzymes of the phenylalanine/tyrosine degradation pathway, caused the death of insects after a blood meal. This was confirmed by using the HPPD inhibitor mesotrione, which selectively killed hematophagous arthropods but did not affect non-hematophagous insects. In addition, mosquitoes and kissing bugs died after feeding on mice that had previously received a therapeutic effective oral dose (1 mg/kg) of nitisinone, another HPPD inhibitor used in humans for the treatment of tyrosinemia type I [3]. These findings indicate that HPPD (and TAT) can be a target for the selective control of blood-sucking disease vector populations. Because HPPD inhibitors are extensively used as herbicides and in medicine, these compounds may provide an alternative less toxic to humans and more environmentally friendly than the conventional neurotoxic insecticides that are currently used, with the ability to affect only hematophagous arthropods.
- Published
- 2016
14. Lack of miR-133a Decreases Contractility of Diabetic Hearts: A Role for Novel Cross Talk Between Tyrosine Aminotransferase and Tyrosine Hydroxylase
- Author
-
Neeru M. Sharma, Shyam Sundar Nandi, Paras Kumar Mishra, Hong Zheng, Kaushik P. Patel, and Hamid R. Shahshahan
- Subjects
0301 basic medicine ,Male ,medicine.medical_specialty ,Tyrosine 3-Monooxygenase ,Endocrinology, Diabetes and Metabolism ,Blotting, Western ,Mice, Transgenic ,Biology ,Pathophysiology ,Diabetes Mellitus, Experimental ,Contractility ,Rats, Sprague-Dawley ,03 medical and health sciences ,Norepinephrine ,Tyrosine aminotransferase ,Downregulation and upregulation ,Internal medicine ,Receptors, Adrenergic, beta ,Internal Medicine ,medicine ,Animals ,Humans ,Myocytes, Cardiac ,Tyrosine ,Receptor ,Tyrosine Transaminase ,Tyrosine hydroxylase ,Reverse Transcriptase Polymerase Chain Reaction ,Myocardium ,Hemodynamics ,Streptozotocin ,Immunohistochemistry ,Myocardial Contraction ,Rats ,MicroRNAs ,030104 developmental biology ,Endocrinology ,HEK293 Cells ,Catecholamine ,medicine.drug - Abstract
MicroRNAs (miRNAs) have a fundamental role in diabetic heart failure. The cardioprotective miRNA-133a (miR-133a) is downregulated, and contractility is decreased in diabetic hearts. Norepinephrine (NE) is a key catecholamine that stimulates contractility by activating β-adrenergic receptors (β-AR). NE is synthesized from tyrosine by the rate-limiting enzyme, tyrosine hydroxylase (TH), and tyrosine is catabolized by tyrosine aminotransferase (TAT). However, the cross talk/link between TAT and TH in the heart is unclear. To determine whether miR-133a plays a role in the cross talk between TH and TAT and regulates contractility by influencing NE biosynthesis and/or β-AR levels in diabetic hearts, Sprague-Dawley rats and miR-133a transgenic (miR-133aTg) mice were injected with streptozotocin to induce diabetes. The diabetic rats were then treated with miR-133a mimic or scrambled miRNA. Our results revealed that miR-133a mimic treatment improved the contractility of the diabetic rat’s heart concomitant with upregulation of TH, cardiac NE, β-AR, and downregulation of TAT and plasma levels of NE. In miR-133aTg mice, cardiac-specific miR-133a overexpression prevented upregulation of TAT and suppression of TH in the heart after streptozotocin was administered. Moreover, miR-133a overexpression in CATH.a neuronal cells suppressed TAT with concomitant upregulation of TH, whereas knockdown and overexpression of TAT demonstrated that TAT inhibited TH. Luciferase reporter assay confirmed that miR-133a targets TAT. In conclusion, miR-133a controls the contractility of diabetic hearts by targeting TAT, regulating NE biosynthesis, and consequently, β-AR and cardiac function.
- Published
- 2016
15. Tyrosine impairs enzymes of energy metabolism in cerebral cortex of rats
- Author
-
Cláudia Funchal, Rodrigo Binkowski de Andrade, Tanise Gemelli, Denise Bertin Rojas, Clovis Milton Duval Wannmacher, and Carlos Severo Dutra-Filho
- Subjects
medicine.medical_specialty ,Pyruvate Kinase ,Clinical Biochemistry ,Biology ,medicine.disease_cause ,Creatine ,Tyrosinemia ,chemistry.chemical_compound ,Tyrosine aminotransferase ,Internal medicine ,medicine ,Animals ,Humans ,Rats, Wistar ,Tyrosine ,Molecular Biology ,Tyrosine Transaminase ,Tyrosinemia type II ,Cerebral Cortex ,Tyrosinemias ,Adenylate Kinase ,Cell Biology ,General Medicine ,medicine.disease ,Glutathione ,Mitochondria ,Rats ,Enzyme Activation ,Disease Models, Animal ,Endocrinology ,chemistry ,biology.protein ,Creatine kinase ,Nervous System Diseases ,Energy Metabolism ,Oxidative stress ,Pyruvate kinase - Abstract
Tyrosine levels are abnormally elevated in tissues and physiological fluids of patients with inborn errors of tyrosine catabolism, especially in tyrosinemia type II, which is caused by deficiency of tyrosine aminotransferase and provokes eyes, skin, and central nervous system disturbances. Considering that the mechanisms of brain damage in these disorders are poorly known, in this study, we investigated the in vivo and in vitro effects of tyrosine on some parameters of energy metabolism in cerebral cortex of 14-day-old Wistar rats. We observed that 2 mM tyrosine inhibited in vitro the pyruvate kinase (PK) activity and that this inhibition was prevented by 1 mM reduced glutathione with 30, 60, and 90 min of preincubation. Moreover, administration of tyrosine methyl ester (TME) (0.5 mg/g of body weight) decreased the activity of PK and this reduction was prevented by pre-treatment with creatine (Cr). On the other hand, tyrosine did not alter adenylate kinase (AK) activity in vitro, but administration of TME enhanced AK activity not prevented by Cr pre-treatment. Finally, TME administration decreased the activity of CK from cytosolic and mitochondrial fractions and this diminution was prevented by Cr pre-treatment. The results suggest that tyrosine alters essential sulfhydryl groups necessary for CK and PK functions, possibly through oxidative stress. In case this also occurs in the patients, it is possible that energy metabolism alterations may contribute, along with other mechanisms, to the neurological dysfunction of hypertyrosinemias.
- Published
- 2012
16. Azaxanthene Based Selective Glucocorticoid Receptor Modulators: Design, Synthesis, and Pharmacological Evaluation of (S)-4-(5-(1-((1,3,4-Thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and Its Methylene Homologue (BMS-791826)
- Author
-
Hua Gong, Ling Gao, Joel C. Barrish, Mark D. Cunningham, Sium Habte, Julie Carman, John E. Somerville, Steven G. Nadler, Christine Burke, John H. Dodd, Jin Hong Wang, Victor R. Guarino, Arthur M. Doweyko, David J. Shuster, David S. Weinstein, Deborah A. Holloway, and Luisa Salter-Cid
- Subjects
Male ,Models, Molecular ,Transcriptional Activation ,Agonist ,medicine.drug_class ,Stereochemistry ,Interleukin-1beta ,Stereoisomerism ,In Vitro Techniques ,Response Elements ,Partial agonist ,Rats, Sprague-Dawley ,Structure-Activity Relationship ,Transactivation ,Receptors, Glucocorticoid ,Glucocorticoid receptor ,Glutamate-Ammonia Ligase ,Cell Line, Tumor ,Thiadiazoles ,Drug Discovery ,medicine ,Animals ,Edema ,Humans ,Structure–activity relationship ,Receptor ,Tyrosine Transaminase ,Transrepression ,Tumor Necrosis Factor-alpha ,Chemistry ,Anti-Inflammatory Agents, Non-Steroidal ,Alkaline Phosphatase ,Arthritis, Experimental ,Rats ,Drug Partial Agonism ,Transcription Factor AP-1 ,Rats, Inbred Lew ,Molecular Medicine ,Heterocyclic Compounds, 3-Ring - Abstract
Structurally novel 5H-chromeno[2,3-b]pyridine (azaxanthene) selective glucocorticoid receptor (GR) modulators have been identified. A screening paradigm utilizing cellular assays of GR-mediated transrepression of proinflammatory transcription factors and transactivation of GR-dependent genes combined with three physiologically relevant assays of cytokine induction in human whole blood has allowed for the identification of high affinity, selective GR ligands that display a broad range of pharmacological profiles. Agonist efficacy in reporter assays can be tuned by halogenation of a pendent phenyl ring and correlates well with efficacy for cytokine inhibition in human whole blood. A hypothetical binding mode is proposed, invoking an expanded ligand binding pocket resembling that of arylpyrazole-bound GR structures. Two compounds of close structural similarity (35 and 37; BMS-776532 and BMS-791826, respectively) have been found to maintain distinct and consistent levels of partial agonist efficacy across several assays, displaying anti-inflammatory activity comparable to that of prednisolone 2 in suppressing cytokine production in whole blood and in rodent models of acute and chronic inflammation.
- Published
- 2011
17. Abrogation of Glucocorticoid Receptor Dimerization Correlates with Dissociated Glucocorticoid Behavior of Compound A
- Author
-
Wim Vanden Berghe, Fatima Allie-Reid, Koch Visser, Guy Haegeman, Donita Africander, Michael Vismer, Steven Robertson, Karolien De Bosscher, Ann Louw, A Binder, and Janet P. Hapgood
- Subjects
Transcriptional Activation ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Steroid hormone receptor ,Gene Expression ,Biology ,Tritium ,Biochemistry ,Dexamethasone ,Phosphates ,Mice ,Structure-Activity Relationship ,Transactivation ,Receptors, Glucocorticoid ,Glucocorticoid receptor ,Tyrosine aminotransferase ,Genes, Reporter ,Cell Line, Tumor ,Internal medicine ,Chlorocebus aethiops ,medicine ,Transcriptional regulation ,Animals ,Humans ,Gene Regulation ,Citrates ,Rats, Wistar ,Promoter Regions, Genetic ,Glucocorticoids ,Molecular Biology ,Tyrosine Transaminase ,Transrepression ,Neurons ,Transcortin ,Adenine ,Liver Neoplasms ,Wild type ,Cell Biology ,Rats ,Cell biology ,Glucose ,Endocrinology ,Mutagenesis ,COS Cells ,Dimerization ,hormones, hormone substitutes, and hormone antagonists ,Glucocorticoid ,medicine.drug - Abstract
Compound A (CpdA), a dissociated glucocorticoid receptor modulator, decreases corticosteroid-binding globulin (CBG), adrenocorticotropic hormone (ACTH), and luteneinizing hormone levels in rats. Whether this is due to transcriptional regulation by CpdA is not known. Using promoter reporter assays we show that CpdA, like dexamethasone (Dex), directly transrepresses these genes. Results using a rat Cbg proximal-promoter reporter construct in BWTG3 and HepG2 cell lines support a glucocorticoid receptor (GR)-dependent transrepression mechanism for CpdA. However, CpdA, unlike Dex, does not result in transactivation via glucocorticoid-responsive elements within a promoter reporter construct even when GR is co-transfected. The inability of CpdA to result in transactivation via glucocorticoid-responsive elements is confirmed on the endogenous tyrosine aminotransferase gene, whereas transrepression ability is confirmed on the endogenous CBG gene. Consistent with a role for CpdA in modulating GR activity, whole cell binding assays revealed that CpdA binds reversibly to the GR, but with lower affinity than Dex, and influences association of [(3)H]Dex, but has no effect on dissociation. In addition, like Dex, CpdA causes nuclear translocation of the GR, albeit to a lesser degree. Several lines of evidence, including fluorescence resonance energy transfer, co-immunoprecipitation, and nuclear immunofluorescence studies of nuclear localization-deficient GR show that CpdA, unlike Dex, does not elicit ligand-induced GR dimerization. Comparison of the behavior of CpdA in the presence of wild type GR to that of Dex with a dimerization-deficient GR mutant (GR(dim)) strongly supports the conclusion that loss of dimerization is responsible for the dissociated behavior of CpdA.
- Published
- 2010
18. Bone morphogenetic protein-4 induced Rat hepatic progenitor cell (WB-F344 cell) differentiation toward hepatocyte lineage
- Author
-
Frank J. Burzynski, Jianghong Fan, Qiaomei Dai, Yuewen Gong, Hong Shen, and Gerald Y. Minuk
- Subjects
Time Factors ,Physiology ,medicine.medical_treatment ,Cellular differentiation ,Clinical Biochemistry ,Bone Morphogenetic Protein 4 ,Transfection ,Cell Line ,Smad1 Protein ,Albumins ,CCAAT-Enhancer-Binding Protein-alpha ,medicine ,Animals ,Cell Lineage ,Phosphorylation ,Progenitor cell ,Tyrosine Transaminase ,Mitogen-Activated Protein Kinase 1 ,Mitogen-Activated Protein Kinase 3 ,biology ,Stem Cells ,Growth factor ,Cell Differentiation ,Bone Morphogenetic Protein Receptors ,Cell Biology ,Transforming growth factor beta ,Molecular biology ,Recombinant Proteins ,Rats ,Endothelial stem cell ,medicine.anatomical_structure ,Bone morphogenetic protein 4 ,Hepatocyte ,embryonic structures ,Glucose-6-Phosphatase ,Hepatocytes ,biology.protein ,Stem cell ,Biomarkers - Abstract
Hepatic progenitor cells are local stem cells in the liver and they can be differentiated into either hepatocytes or cholangiocytes depending on different stimulations. These stimulations include extracellular growth factors and intracellular transcription factors. Bone morphogenetic protein 4 (BMP4) is a member of transforming growth factor beta (TGF-β) superfamily and was first identified as growth factor to induce ectopic bone formation from skeletal muscle. Role of BMP4 in the liver is still unclear especially its role in hepatic progenitor cells (HPCs) differentiation. BMP4 was used to stimulate rat HPCs (WB-F344 cells) and differentiation of WB-F344 cells was investigated by reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot analysis. Both adenovirus delivered BMP4 and recombinant BMP4 were able to induce expression of hepatocyte markers such as albumin, TAT-1, and G6Pase but not cholangiocyte markers such as β4-integrin and CK19. BMP4 induced differentiation of WB-F344 cells toward hepatocytes was mediated by increase in phosphorylation of Smad1 and ERK1/2. Moreover, BMP4 also stimulated expression of transcription factor—C/EBP-α, which involved in differentiation of WB-F344 cells toward hepatocytes. BMP4 is able to stimulate WB-F344 cells differentiation toward hepatocyte lineage. J. Cell. Physiol. 220: 72–81, 2009. © 2009 Wiley-Liss, Inc.
- Published
- 2009
19. Identification of Marker Genes for Lipid-Lowering Effect of a Short-Chain Fructooligosaccharide by DNA Microarray Analysis
- Author
-
Tomoko Nemoto, Jinichiro Koga, Ichiro Matsumoto, Hidetoshi Kubota, Minoru Kanegae, Koichiro Murashima, and Tomoyuki Fukasawa
- Subjects
Genetic Markers ,Male ,Gene Expression ,Oligosaccharides ,Fructose ,Biology ,Marker gene ,Mixed Function Oxygenases ,Tyrosine aminotransferase ,Gene expression ,Animals ,Coenzyme A ,Pharmacology (medical) ,Enzyme Inhibitors ,Rats, Wistar ,Gene ,Triglycerides ,Hypolipidemic Agents ,Tyrosine Transaminase ,Lipoprotein lipase ,Nutrition and Dietetics ,Reverse Transcriptase Polymerase Chain Reaction ,Fructooligosaccharide ,Lipid metabolism ,DNA ,Lipid Metabolism ,Microarray Analysis ,Molecular biology ,Enzymes ,Up-Regulation ,Phytanic Acid ,Lipoprotein Lipase ,Liver ,lipids (amino acids, peptides, and proteins) ,DNA microarray ,Food Science - Abstract
Administration of short-chain fructooligosaccharide (scFOS) is known to lower serum triglyceride levels in rats fed a high-fat diet, but the molecular mechanisms remain unclear. This study aimed to identify marker genes for lipid-lowering effect of scFOS administration. The changes in hepatic gene expressions in rats fed scFOS were investigated using DNA microarray and quantitative RT-PCR analysis. The DNA microarray showed that phytanoyl-CoA 2-hydroxylase 2 (Phyh2), lipoprotein lipase (Lpl) and tyrosine aminotransferase (Tat) were significantly affected by scFOS administration (p < .05). Since Lpl is involved in lipid metabolism, the up-regulation of Lpl in the liver can be a potential marker of the lipid-lowering effect of scFOS.
- Published
- 2009
20. Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes
- Author
-
Raymond D. Blind and Michael J. Garabedian
- Subjects
Transcriptional Activation ,Gene isoform ,Leucine zipper ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Biology ,Biochemistry ,Article ,Dexamethasone ,Receptors, Glucocorticoid ,Endocrinology ,Glucocorticoid receptor ,Cell Line, Tumor ,Gene expression ,medicine ,Animals ,Humans ,Protein Isoforms ,RNA, Messenger ,Phosphorylation ,Molecular Biology ,Transcription factor ,DNA Primers ,Tyrosine Transaminase ,Binding Sites ,Base Sequence ,DNA ,Cell Biology ,Arylsulfotransferase ,Molecular biology ,Rats ,Molecular Medicine ,Chromatin immunoprecipitation ,Glucocorticoid ,Transcription Factors ,medicine.drug - Abstract
The human glucocorticoid receptor (GR) is phosphorylated on its N-terminus at three major sites (S203, S211 and S226) within activation function 1 (AF1). Although GR has been shown to assemble at glucocorticoid responsive elements (GREs) in the presence of hormone, the timing and specificity of GR phospho-isoform recruitment to receptor target genes has not been established. Using chromatin immunoprecipitation (ChIP) and GR phosphorylation site-specific antibodies, we examined GR phospho-isoform recruitment to several glucocorticoid-induced genes including tyrosine aminotransferase (tat) and sulfonyltransferase-1A1 (sult) in rat hepatoma cells, and the glucocorticoid-induced leucine zipper (gilz) gene in human U2OS cells. GR P-S211 and GR P-S226 isoforms were efficiently recruited to the tat, sult and gilz GREs in a hormone-dependent manner. In contrast, the GR P-S203 isoform displayed no significant recruitment to any GREs of the genes analyzed, consistent with its lack of nuclear accumulation. Interestingly, the kinetics of GR P-S211 and GR P-S226 recruitment differed among genes. Our findings indicate that GR phospho-isoforms selectively occupy GR target genes, and suggests gene specific requirements for GR phosphorylation in receptor-dependent transcriptional activation.
- Published
- 2008
21. Role of glucocorticoids and resident liver macrophages in induction of tyrosine aminotransferase
- Author
-
L. E. Panin and I. F. Usynin
- Subjects
Male ,medicine.medical_specialty ,Hydrocortisone ,Kupffer Cells ,Stimulation ,Biology ,Biochemistry ,Tyrosine aminotransferase ,Internal medicine ,medicine ,Animals ,Macrophage ,Inducer ,Rats, Wistar ,Enzyme inducer ,Cells, Cultured ,Tyrosine Transaminase ,Dextran Sulfate ,General Medicine ,Enzyme assay ,In vitro ,Rats ,medicine.anatomical_structure ,Endocrinology ,Hepatocyte ,biology.protein - Abstract
Administration of cortisol to an animal induces tyrosine aminotransferase (TAT) in the liver. A similar effect was observed after stimulation of resident liver macrophages (Kupffer cells) by dextran sulfate. Actinomycin D completely blocks enzyme induction both by cortisol and dextran sulfate, whereas their combined effect gives an additive result. In primary culture of hepatocytes, dextran sulfate inhibits TAT activity, but conditioned macrophage medium reliably increases enzyme activity in hepatocytes. However, incubation of isolated macrophages in the presence of dextran sulfate and such medium transfer into hepatocyte culture results in even more pronounced increase in TAT activity. In a combined culture of hepatocytes and non-parenchymal liver cells, reproducing intercellular interactions in vitro, cortisol and non-parenchymal cells exhibit an additive effect on TAT activity. These results show that liver macrophages release a factor of unknown nature launching the mechanism of TAT induction independently of cortisol, a classic TAT inducer.
- Published
- 2008
22. New forms of hereditary tyrosinemia type II in mink: Hepatic tyrosine aminotransferase defect
- Author
-
Knud Christensen, Per Henriksen, and Hilmer Sørensen
- Subjects
Male ,medicine.medical_specialty ,Enzyme defect ,Urine ,Frequent urination ,Tyrosinemia ,Tyrosine aminotransferase ,biology.animal ,Internal medicine ,Genetics ,medicine ,Animals ,Amino Acids ,Mink ,Tyrosine ,Amino Acid Metabolism, Inborn Errors ,Tyrosine Transaminase ,biology ,General Medicine ,medicine.disease ,Hereditary tyrosinemia ,Endocrinology ,Liver ,Female ,medicine.symptom - Abstract
Three different forms of hereditary tyrosinemia type II, with some of the features described for the Richner-Hanhart's syndrome, occur in mink (Mustela vison Schreb.). These disorders are inherited as simple autosomal recessive characters. The main symptoms of the diseases are watery dull eyes, frequent urination, alteration of the hair/skin on the toes and a highly elevated level of tyrosine in blood and urine. An enzyme defect in hepatic tyrosine aminotransferase (EC 2.6.1.5) is considered as the reason of these three forms of the mink disease. Differences between these forms of hereditary tyrosinemia in mink now described lie among other things in the time of onset, duration and severity of the disese.
- Published
- 2008
23. Trypanosoma cruzi: Characterisation of the gene encoding tyrosine aminotransferase in benznidazole-resistant and susceptible populations
- Author
-
Silvane M. F. Murta, Philippe Nirdé, Juciane V. Rego, Fernanda de Bruycker Nogueira, Alvaro J. Romanha, and Hélida Monteiro de Andrade
- Subjects
Chagas disease ,Transcription, Genetic ,Trypanosoma cruzi ,Blotting, Western ,Immunology ,Drug Resistance ,Drug resistance ,Gene Expression Regulation, Enzymologic ,Tyrosine aminotransferase ,parasitic diseases ,medicine ,Animals ,RNA, Messenger ,Cloning, Molecular ,Nifurtimox ,Gene ,Tyrosine Transaminase ,biology ,Reverse Transcriptase Polymerase Chain Reaction ,Kinetoplastida ,General Medicine ,DNA, Protozoan ,Blotting, Northern ,biology.organism_classification ,medicine.disease ,Trypanocidal Agents ,Virology ,Molecular biology ,Recombinant Proteins ,Electrophoresis, Gel, Pulsed-Field ,Blotting, Southern ,Infectious Diseases ,Nitroimidazoles ,Benznidazole ,Parasitology ,RNA, Protozoan ,medicine.drug - Abstract
Various biochemical differences exist between mammalian tyrosine aminotransferase (TAT) and its analogue in Trypanosoma cruzi (TcTAT), the causative agent of Chagas disease. Moreover, TcTAT is over-expressed in strains of the parasite that are resistant to benznidazole (BZ), a drug currently used in chemotherapy. TAT has thus been indicated as a potential target for the development of new chemotherapeutic agents. In the present study, the TcTAT gene has been characterised in 14 BZ-resistant and susceptible strains and clones of T. cruzi. A unique transcript of 2.0 kb and similar levels of TcTAT mRNA were observed in all parasite populations. TcTAT gene is organized in a tandem multicopy array and is located on 8 chromosomal bands that vary from 785–2500 kb. No amplification of TcTAT was observed in the parasite genome. A 42 kDa protein expressed by TcTAT was present in all T. cruzi samples. The results suggest that TcTAT is not directly associated with the T. cruzi drug resistance phenotype. However, it may act as a general secondary compensatory mechanism or stress response factor rather than as a key component of the specific primary resistance mechanism in T. cruzi.
- Published
- 2008
24. Serine dehydratase and tyrosine aminotransferase activities increased by long-term starvation and recovery by refeeding in rainbow trout (Oncorhynchus mykiss)
- Author
-
José A. Lupiáñez, Juan Peragón, M. de la Higuera, and Juan B. Barroso
- Subjects
L-Serine Dehydratase ,medicine.medical_specialty ,Time Factors ,Physiology ,Biology ,Serine dehydratase ,Tyrosine aminotransferase ,Internal medicine ,Genetics ,medicine ,Animals ,Muscle, Skeletal ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,Tyrosine Transaminase ,chemistry.chemical_classification ,Starvation ,Catabolism ,Body Weight ,Organ Size ,biology.organism_classification ,Amino acid ,Trout ,Endocrinology ,Liver ,chemistry ,Food ,Oncorhynchus mykiss ,Animal Science and Zoology ,Specific activity ,Rainbow trout ,medicine.symptom - Abstract
Here, we study a cycle of long-term starvation followed by refeeding in relation to the kinetics of serine dehydratase (SerDH) and tyrosine aminotransferase (TyrAT) in rainbow trout (Oncorhynchus mykiss). We determine SerDH- and TyrAT- specific activity at different substrate concentrations in liver and white muscle of juvenile trout starved for 70 days and then refed for 6 hr, 32 hr, 4 days, and 9 days. SerDH showed a hyperbolic kinetic with a K(m) for L-serine of 77.07+/-8.78 mM in the liver of control trout. After 70 days of starvation, the SerDH activity at saturate substrate concentration rose 100% over control. No significant changes were found in the K(m) values of the enzyme. After refeeding, the SerDH activity declined to control values. TyrAT also showed a hyperbolic kinetic with a K(m) for L-tyrosine of 1.86+/-0.12 and 2.55+/-0.57 mM in liver and white muscle, respectively. In starved trout, TyrAT activity in liver and white muscle was about 64 and 267%, respectively, higher than control. After 9 days of refeeding, the control values recovered, although, at 6 hr of refeeding, hepatic TyrAT activity was higher than that for starvation. This work shows that SerDH and TyrAT are present in rainbow trout and that the two enzymes have regulatory functions in the catabolism of their respective amino acids in this species.
- Published
- 2007
25. Gene therapy for liver enzyme deficiencies: what have we learned from models for Crigler–Najjar and tyrosinemia?
- Author
-
Tuan Huy Nguyen and Nicolas Ferry
- Subjects
Genetic enhancement ,Disease ,Gene delivery ,Bioinformatics ,Tyrosinemia ,Liver enzyme ,Animals ,Humans ,Medicine ,Vector (molecular biology) ,Glucuronosyltransferase ,Crigler-Najjar Syndrome ,Tyrosine Transaminase ,Tyrosinemia type II ,Hepatology ,biology ,Tyrosinemias ,business.industry ,Gastroenterology ,Genetic Therapy ,medicine.disease ,biology.organism_classification ,Virology ,Disease Models, Animal ,Lentivirus ,business - Abstract
The liver is the site of numerous metabolic inherited diseases. It has unique features that make it compliant to various gene therapy approaches. Many vector types and gene delivery strategies have been evaluated during the past 20 years in a number of animal models of metabolic liver diseases. However, the complete cure of inherited liver deficiencies by gene therapy in relevant animal models were only reported recently. These successes were achieved thanks to major advances in vector technology. In this review, we will focus on Crigler-Najjar disease and hereditary tyrosinemia, two paradigmatic examples of the two categories of enzymatic liver deficiencies: type I, in which the genetic defect does not affect liver histology; and type II, in which liver lesions are present.
- Published
- 2007
26. Two populations of Thy1-positive mesenchymal cells regulate in vitro maturation of hepatic progenitor cells
- Author
-
Takashi Tsuruo, Hajime Kubo, Naoya Fujita, Hideaki Fujii, Toshitaka Hoppo, Takamichi Ishii, Iwao Ikai, Takafumi Machimoto, Kentaro Yasuchika, Jun K. Yamashita, and Naoko Kamo
- Subjects
Integrins ,Physiology ,Liver cytology ,Cystic Fibrosis Transmembrane Conductance Regulator ,Gene Expression ,Antigens, CD34 ,Cell Separation ,Integrin alpha6 ,Biology ,Desmin ,Flow cytometry ,Mesoderm ,Mice ,Microscopy, Electron, Transmission ,Antigen ,Physiology (medical) ,medicine ,Animals ,Vimentin ,Progenitor cell ,Cell Proliferation ,Tyrosine Transaminase ,Membrane Glycoproteins ,Hepatology ,medicine.diagnostic_test ,Cell growth ,Stem Cells ,Mesenchymal stem cell ,Gastroenterology ,Cell Differentiation ,Flow Cytometry ,Molecular biology ,Actins ,Coculture Techniques ,Tryptophan Oxygenase ,In vitro ,Cell biology ,In vitro maturation ,Mice, Inbred C57BL ,Liver ,Culture Media, Conditioned ,embryonic structures ,Thy-1 Antigens - Abstract
We previously reported that the in vitro maturation of CD49f+Thy1−CD45− (CD49f positive) fetal hepatic progenitor cells (HPCs) is supported by Thy1-positive mesenchymal cells derived from the fetal liver. These mesenchymal cell preparations contain two populations, one of a cuboidal shape and the other spindle shaped in morphology. In this study, we determined that the mucin-type transmembrane glycoprotein gp38 could distinguish cuboidal cells from spindle cells by immunocytochemistry. RT-PCR analysis revealed differences between isolated CD49f±Thy1+gp38+CD45− (gp38 positive) cells and CD49f±Thy1+gp38−CD45− (gp38 negative) cells, whereas both cells expressed mesenchymal cell markers. The coculture with gp38-positive cells promoted the maturation of CD49f-positive HPCs, which was estimated by positivity for periodic acid-Schiff (PAS) staining, whereas the coculture with gp38-negative cells maintained CD49f-positive HPCs negative for PAS staining. The expression of mature hepatocyte markers, such as tyrosine aminotransferase, tryptophan-2,3-dioxygenase, and glucose-6-phosphatase, were upregulated on HPCs by coculture with gp38-positive cells. Furthermore, transmission electron microscopy revealed the acquisition of mature hepatocyte features by HPCs cocultured with gp38-positive cells. This effect on maturation of HPCs was inhibited by the addition of conditioned medium derived from gp38-negative cells. By contrast, the upregulation of bromodeoxyuridine incorporation by HPCs demonstrated the proliferative effect of coculture with gp38-negative cells. In conclusion, these results suggest that in vitro maturation of HPCs promoted by gp38-positive cells may be opposed by an inhibitory effect of gp38-negative cells, which likely maintain the immature, proliferative state of HPCs.
- Published
- 2007
27. Isolation, culture and immortalisation of hepatic oval cells from adult mice fed a choline-deficient, ethionine-supplemented diet
- Author
-
George C.T. Yeoh, Belinda Knight, Janina E.E. Tirnitz-Parker, Joanne N. Tonkin, and John K. Olynyk
- Subjects
Male ,Liver cytology ,Transgene ,Cell ,Cell Culture Techniques ,Gene Expression ,Mice, Transgenic ,Cell Separation ,Biology ,Biochemistry ,Connexins ,Choline ,Cell therapy ,Mice ,medicine ,Animals ,Ethionine ,Cell Line, Transformed ,Tyrosine Transaminase ,Food, Formulated ,Keratin-19 ,Reverse Transcriptase Polymerase Chain Reaction ,Stem Cells ,Cell Differentiation ,Cell Biology ,Cadherins ,Antigens, Differentiation ,Immunohistochemistry ,Molecular biology ,Liver regeneration ,GATA2 Transcription Factor ,Mice, Inbred C57BL ,Haematopoiesis ,medicine.anatomical_structure ,Liver ,Cell culture ,Immunology ,Hepatocytes ,Thy-1 Antigens ,Immunostaining - Abstract
Oval cells have great potential for use in cell therapy to treat liver disease, however this cannot be achieved until the factors which govern their proliferation and differentiation are better understood. We describe a method to establish primary cultures of murine oval cells, and the derivation of two novel lines from these. Primary cultures from the livers of wildtype or TAT-GRE lacZ transgenic mice subjected to a choline-deficient, ethionine-supplemented diet comprised up to 80% oval cells at day 7 based on A6 or CK19 staining. Cell lines were clonally derived, which underwent spontaneous immortalisation following prolonged maintenance in culture. Immunostaining and RT-PCR demonstrated they express hepatocytic and biliary markers and they were therefore termed "bipotential murine oval liver" (BMOL) cells. Under proliferating culture conditions, BMOL or BMOL-TAT cells abundantly expressed oval cell and biliary markers, whereas mature hepatocytic markers were upregulated when the growth conditions were changed to facilitate differentiation. Hepatic differentiation of BMOL-TAT cells could be traced by measuring the expression of their lacZ transgene, which is driven by a promoter element from tyrosine aminotransferase (TAT), a marker of adult hepatocytes. Interestingly, haematopoietic markers were upregulated in superconfluent cultures, indicating a possible multipotentiality. None of the cell lines grew in semi-solid agar, nor did they form tumours in nude mice, suggesting they are non-tumourigenic. These novel murine oval cell lines, together with a reliable method for isolation and culture of primary oval cells, will provide a useful tool for investigating the contribution of oval cells to liver regeneration.
- Published
- 2007
28. Effect of Growth Hormone in an Experimental Model of Protein Hypercatabolism Induced by Glucocorticoids
- Author
-
Rafael Simó, Peter J Trainer, A. Cantón, and Eva Martínez-Cáceres
- Subjects
Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Biology ,Placebo ,Biochemistry ,Dexamethasone ,chemistry.chemical_compound ,Subcutaneous injection ,Receptors, Glucocorticoid ,Endocrinology ,Glucocorticoid receptor ,Tyrosine aminotransferase ,Adrenocorticotropic Hormone ,Metabolic Diseases ,Corticosterone ,Internal medicine ,medicine ,Animals ,Insulin-Like Growth Factor I ,Rats, Wistar ,Glucocorticoids ,Tyrosine Transaminase ,Human Growth Hormone ,Body Weight ,Biochemistry (medical) ,Proteins ,General Medicine ,Rats ,Disease Models, Animal ,Gene Expression Regulation ,chemistry ,Hypermetabolism ,Glucocorticoid ,medicine.drug - Abstract
OBJECTIVE: The aims of the study were to evaluate whether growth hormone could be beneficial in a model of hypercatabolism induced by glucocorticoids and to examine its effects on ACTH, corticosterone and IGF-1 levels. The effects of growth hormone on the expression of both glucocorticoid receptor and tyrosine aminotransferase were also evaluated. METHODS: Fifty Wistar rats were divided into five groups and treated as follows: (A) daily subcutaneous injection of growth hormone (4.8 IU/kg/day) and oral placebo, (B) daily injection of placebo and oral dexamethasone (3 mg/kg/day), (C) daily injection of growth hormone and oral dexamethasone, (D) daily injection of placebo and oral placebo, and (E) no treatment. The animals were decapitated seven days after initiating treatment. RESULTS: Growth hormone did not modify the weight loss induced by dexamethasone. Glucocorticoid receptor expression was significantly lower in group A than in group E. An increase in tyrosine aminotransferase was observed in group C. CONCLUSION: Growth hormone did not exert any beneficial effect in this model of hypercatabolism. Growth hormone decreased glucocorticoid receptor expression. This fact could explain its beneficial effect when protein hypercatabolism is not the predominant phenomenon. Growth hormone induced the hyperexpression of tyrosine aminotransferase, thus suggesting an amplifying effect on the glucocorticoid action.
- Published
- 2006
29. Mercury influences rat liver tyrosine aminotransferase activity and induction by dexamethasone
- Author
-
Sanja Manitasević, Jelena Brkljačić, Ivana Elaković, Gordana Matić, and Jadranka Dundjerski
- Subjects
medicine.medical_specialty ,medicine.drug_class ,medicine.medical_treatment ,Tyrosine Transaminase ,Anti-Inflammatory Agents ,chemistry.chemical_element ,Toxicology ,Dexamethasone ,Cytosol ,Receptors, Glucocorticoid ,Tyrosine aminotransferase ,In vivo ,Internal medicine ,medicine ,Animals ,Enzyme inducer ,biology ,Spectrophotometry, Atomic ,Mercury ,Rats ,Mercury (element) ,Steroid hormone ,Endocrinology ,Liver ,chemistry ,Enzyme Induction ,biology.protein ,Corticosteroid ,medicine.drug - Abstract
The effects of mercury (Hg) on basal and dexamethasone-induced tyrosine aminotransferase (TAT) activity in rat liver were studied. Comparison of TAT activity after in vitro and in vivo mercury application revealed the influence of the metal only when applied in vivo, suggesting that the effects are expressed at the level of TAT gene transcription. Intraperitoneal administration of mercury at 1, 2 or 3 mg Hg kg−1 b.w. 4 h before decapitation was shown to stimulate the basal activity of TAT. The most prominent increase was observed 4 h after the metal administration. When applied at 1 and 2 mg Hg kg−1 b.w. mercury was also shown to reduce partially the extent of the enzyme induction by dexamethasone, which was injected intraperitoneally at 5 mg kg−1 b.w. 5 h before death. The highest dose of mercury (3 mg Hg kg−1 b.w.) almost completely abolished the dexamethasone effect. The finding that mercury increases basal activity of the enzyme while decreasing its induction by dexamethasone suggests that stimulatory effects of this metal on TAT activity are probably mediated by factors other than glucocorticoids. Copyright © 2005 John Wiley & Sons, Ltd.
- Published
- 2006
30. The genetic tyrosinemias
- Author
-
C. Ronald Scott
- Subjects
medicine.medical_specialty ,education.field_of_study ,Tyrosinemias ,business.industry ,Population ,medicine.disease ,Tyrosinemia Type I ,Tyrosinemia ,Endocrinology ,Tyrosine aminotransferase ,Internal medicine ,Genetics ,medicine ,Animals ,Humans ,Tyrosine ,Fumarylacetoacetate hydrolase ,Tyrosinemia type III ,education ,business ,Genetics (clinical) ,Tyrosine Transaminase ,Tyrosinemia type II - Abstract
The genetic tyrosinemias are characterized by the accumulation of tyrosine in body fluids and tissues. The most severe form of tyrosinemia, Type I, is a devastating disorder of childhood that causes liver failure, painful neurologic crises, rickets, and hepatocarcinoma. This disorder is caused by a deficiency of fumarylacetoacetate hydrolase (FAH). If untreated, death typically occurs at less than 2 years of age, with some chronic forms allowing longer survival. It has a prevalence of about 1 in 100,000 newborns in the general population. Oculocutaneous tyrosinemia, Type II, is caused by a deficiency of tyrosine aminotransferase (TAT). It clinically presents with hyperkeratotic plaques on the hands and soles of the feet and photophobia due to deposition of tyrosine crystals within the cornea. Tyrosinemia Type III is an extremely rare disorder caused by a deficiency of 4-hydroxyphenylpyruvic dioxygenase. It has been associated with ataxia and mild mental retardation. These disorders are diagnosed by observing elevated tyrosine by plasma amino acid chromatography and characteristic tyrosine metabolites by urine organic acid analysis. In tyrosinemia Type I, methionine is also elevated, reflecting impaired hepatocellular function. Urine organic acids show elevated p-hydroxy-phenyl organic acids in each type of tyrosinemia, and the pathognomic succinylacetone in tyrosinemia Type I. Diagnosis can be confirmed by enzyme or molecular studies in tyrosinemia Type I. Therapy consists of a diet low in phenylalanine and tyrosine for each of the tyrosinemias and 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) for tyrosinemia Type I.
- Published
- 2006
31. Macromolecular Translocation Inhibitor II (Zn2+-binding Protein, Parathymosin) Interacts with the Glucocorticoid Receptor and Enhances Transcription in Vivo
- Author
-
Kazuki Okamoto and Fumihide Isohashi
- Subjects
Cell Extracts ,Transcription, Genetic ,Immunoprecipitation ,Recombinant Fusion Proteins ,Green Fluorescent Proteins ,Regulatory Sequences, Nucleic Acid ,Biology ,Biochemistry ,Nuclear Receptor Coactivator 1 ,Receptors, Glucocorticoid ,Glucocorticoid receptor ,Chlorocebus aethiops ,Coactivator ,Animals ,Humans ,RNA, Small Interfering ,Luciferases ,Molecular Biology ,Histone Acetyltransferases ,Tyrosine Transaminase ,PELP-1 ,Cell Nucleus ,Binding protein ,Cell Biology ,CREB-Binding Protein ,Molecular biology ,Thymosin ,Nuclear receptor coactivator 1 ,Luminescent Proteins ,COS Cells ,Parathymosin ,Nuclear receptor coactivator 2 ,E1A-Associated p300 Protein ,human activities ,HeLa Cells ,Plasmids ,Transcription Factors - Abstract
Macromolecular translocation inhibitor II (MTI-II), which was first identified as an in vitro inhibitor of binding between the highly purified glucocorticoid receptor (GR) and isolated nuclei, is an 11.5-kDa Zn(2+)-binding protein that is also known as ZnBP or parathymosin. MTI-II is a small nuclear acidic protein that is highly conserved in rats, cows, and humans and widely distributed in mammalian tissues, yet its physiological function is unknown. To elucidate its in vivo function in relation to GR, we transiently transfected mammalian cells with an expression plasmid encoding MTI-II. Unexpectedly, we found that the expression of MTI-II enhances the transcriptional activity of GR. The magnitude of the transcriptional enhancement induced by MTI-II is comparable with that induced by the steroid receptor coactivator SRC-1. In contrast, MTI-II had little effect on the transcriptional activity of estrogen receptor. Immunoprecipitation analysis showed that in the presence of glucocorticoid hormone, GR coprecipitates with MTI-II, and, vice versa, MTI-II coprecipitates with GR. The expression of various deletion mutants of MTI-II revealed that the central acidic domain is essential for the enhancement of GR-dependent transcription. Microscopic analysis of MTI-II fused to green fluorescent protein and GR fused to red fluorescent protein in living HeLa cells showed that MTI-II colocalizes with GR in discrete subnuclear domains in a hormone-dependent manner. Coexpression of MTI-II with the coactivator SRC-1 or p300 further enhances GR-dependent transcription. Immunoprecipitation analysis showed that in the presence of glucocorticoid hormone, p300 and CREB-binding protein are coprecipitated with MTI-II. Furthermore, the knockdown of endogenous MTI-II by RNAi reduces the transcriptional activity of GR in cells. Moreover, expression of MTI-II enhances the glucocorticoid-dependent transcription of the endogenous glucocorticoid-inducible enzyme in cells. Taken together, these results indicate that MTI-II enhances GR-dependent transcription via a direct interaction with GR in vivo. Thus, MTI-II is a new member of the GR-coactivator complex.
- Published
- 2005
32. Repression of GR-Mediated Expression of the Tryptophan Oxygenase Gene by the SWI/SNF Complex during Liver Development
- Author
-
Takeaki Dohda, Shinji Iijima, Yuichi Machida, Hidenori Kaneoka, Yujin Inayoshi, Katsuhide Miyake, and Masaomi Terajima
- Subjects
Transcription, Genetic ,Chromosomal Proteins, Non-Histone ,cells ,genetic processes ,Down-Regulation ,macromolecular substances ,Biochemistry ,Chromatin remodeling ,Receptors, Glucocorticoid ,Gene expression ,medicine ,Animals ,Gene Silencing ,RNA, Small Interfering ,Molecular Biology ,Tyrosine Transaminase ,SWI/SNF complex ,Chemistry ,Gene Expression Regulation, Developmental ,General Medicine ,Chromatin Assembly and Disassembly ,Molecular biology ,Tryptophan Oxygenase ,SWI/SNF ,Chromatin ,enzymes and coenzymes (carbohydrates) ,Trichostatin A ,Liver ,SMARCA4 ,Histone deacetylase ,biological phenomena, cell phenomena, and immunity ,Transcription Factors ,medicine.drug - Abstract
The chromatin remodeling complex, SWI/SNF, is known to regulate the transcription of several genes by altering the chromatin structure in an ATP-dependent manner. SWI/ SNF exclusively contains BRG1 or BRM as an ATPase subunit. In the present study, we studied the role of SWI/SNF containing BRM or BRG1 in the expression of the liver-specific tryptophan oxygenase (TO) and tyrosine aminotransferase genes. Chromatin remodeling factors significantly repressed the expression of these genes induced by glucocorticoid receptor and dexamethasone. Since the repression was not reversed by trichostatin A treatment, it seemed to be independent of the well-known histone deacetylase pathway. Knock-down of BRG1 by small interfering RNA reversed the repression in primary fetal hepatocytes. These results support a model in which SWI/ SNF containing BRG1 represses late stage-specific TO gene expression at an early stage of liver development.
- Published
- 2005
33. Antidiabetic Activity of Passive Nonsteroidal Glucocorticoid Receptor Modulators
- Author
-
Phong Nguyen, Sue J. Swanson, Jyoti R. Patel, Jiahong Wang, Annika Goos-Nilsson, J.T. Link, Peer B. Jacobson, Zhenping Tian, Marlena Grynfarb, Jia Du, James M. Schmidt, Brad Zinker, Thomas W von Geldern, Steven Fung, Thomas J Reisch, Denise Wilcox, Gary Rotert, Benjamin C. Lane, Bach Hickman, and Bryan Sorensen
- Subjects
Male ,Transcriptional Activation ,Benzylamines ,Hypothalamo-Hypophyseal System ,medicine.medical_specialty ,Side effect ,Pituitary-Adrenal System ,Dexamethasone ,Rats, Sprague-Dawley ,Mice ,Radioligand Assay ,chemistry.chemical_compound ,Cricetulus ,Receptors, Glucocorticoid ,Glucocorticoid receptor ,Genes, Reporter ,Pregnancy ,Cricetinae ,Internal medicine ,Drug Discovery ,medicine ,Animals ,Humans ,Hypoglycemic Agents ,Receptor ,Glucocorticoids ,Cells, Cultured ,Tyrosine Transaminase ,chemistry.chemical_classification ,Sulfonamides ,Triglyceride ,Cholesterol ,Uterus ,Fatty acid ,Alkaline Phosphatase ,Rats ,medicine.anatomical_structure ,Endocrinology ,chemistry ,Hepatocytes ,Molecular Medicine ,Female ,Antagonism ,Hypothalamic–pituitary–adrenal axis - Abstract
Much has been learned about the consequences of glucocorticoid receptor antagonism by studying steroidal active antagonists such as RU-38486 (1). In the liver glucocorticoid receptor antagonism suppresses hepatic glucose production decreasing plasma glucose levels; however, extrahepatic antagonism produces several undesirable side effects including activation of the hypothalamic pituitary adrenal axis. A series of nonsteroidal passive N-(3-dibenzylamino-2-alkyl-phenyl)-methanesulfonamide glucocorticoid receptor modulators was discovered. Liver selective and systemically available members of this series were found and characterized in diabetes and side effect rodent models. A highly liver selective member of this series, acid 14, shows efficacy in the ob/ob model of diabetes. It lowers plasma glucose, cholesterol, and free fatty acid concentrations and reduces the rate of body weight gain. The structurally related systemically available passive modulator 12 lowers glucose, HbA(1c), triglyceride, free fatty acid, and cholesterol levels. Interestingly, it did not acutely activate the hypothalamic pituitary adrenal axis in unstressed CD-1 mice or have the abortive effects observed with 1. These results indicate that passive GR antagonists may have utility as antidiabetic agents.
- Published
- 2005
34. Comparison of the Tyrosine Aminotransferase cDNA and Genomic DNA Sequences of Normal Mink and Mink Affected with Tyrosinemia Type II
- Author
-
Steven R. Leib, David J. Prieur, and Travis C. McGuire
- Subjects
DNA, Complementary ,Molecular Sequence Data ,Animal Diseases ,Tyrosinemia ,Exon ,Tyrosine aminotransferase ,Complementary DNA ,biology.animal ,Genetics ,medicine ,Animals ,Amino Acid Sequence ,Tyrosine ,Mink ,Molecular Biology ,Gene ,In Situ Hybridization, Fluorescence ,Genetics (clinical) ,DNA Primers ,Tyrosine Transaminase ,Tyrosinemia type II ,Base Sequence ,biology ,Tyrosinemias ,Chromosome Mapping ,medicine.disease ,Molecular biology ,Introns ,Biotechnology - Abstract
Type II tyrosinemia, designated Richner-Hanhart syndrome in humans, is a hereditary metabolic disorder with autosomal recessive inheritance characterized by a deficiency of tyrosine aminotransferase activity. Mutations occur in the human tyrosine aminotransferase gene, resulting in high levels of tyrosine and disease. Type II tyrosinemia occurs in mink, and our hypothesis was that it would also be associated with mutation(s) in the tyrosine aminotransferase gene. Therefore, the transcribed cDNA and the genomic tyrosine aminotransferase gene were sequenced from normal and affected mink. The gene extended over 11.9 kb and had 12 exons coding for a predicted 454-amino-acid protein with 93% homology with human tyrosine aminotransferase. FISH analysis mapped the gene to chromosome 8 using the Mandahl and Fredga (1975) nomenclature and chromosome 5 using the Christensen et al. (1996) nomenclature. The hypothesis was rejected because sequence analysis disclosed no mutations in either cDNA or introns that were associated with affected mink. This suggests that an unlinked gene regulatory mutation may be the cause of tyrosinemia in mink.
- Published
- 2005
35. Studies on the Posttranscriptional Site of cAMP Action in the Regulation of the Synthesis of Tyrosine Aminotransferase
- Author
-
Roel Van Wijk, Klaas W. Van De Poll, Harry O. Voorma, and Gerry T. Snoek
- Subjects
Messenger RNA ,Biology ,Biochemistry ,Molecular biology ,Kinetics ,Liver Neoplasms, Experimental ,Tyrosine aminotransferase ,Bucladesine ,Cell culture ,Enzyme Induction ,Protein Biosynthesis ,Dactinomycin ,Animals ,RNA, Messenger ,Cycloheximide ,Cells, Cultured ,Tyrosine Transaminase ,Total protein - Abstract
Synthesis of L-tyrosine:2-oxoglutarate aminotransferase (EC 2.6.1.5) can be induced by N6,O2'-dibutyryl-adenosine 3',5'-monophosphate (Bt2cAMP) in Reuber H35 cell cultures. Actinomycin D fails to block this induction which indicates a target for Bt2cAMP at a posttranscriptional level. We have determined the influence of Bt2cAMP on several translational events during the tyrosine aminotransferase synthesis with the following results. (1) The number of nascent tyrosine aminotransferase chains increased, whereas no effect was measured on the number of nascent total protein chains. (2) The rate of elongation along the tyrosine aminotransferase mRNA and total mRNA is not enhanced by Bt2cAMP. (3) The induced synthesis of tyrosine aminotransferase is more sensitive to the inhibition of elongation. We conclude from our results that Bt2cAMP induces the synthesis of tyrosine aminotransferase by an increase in the rate of initiation on the tyrosine aminotransferase mRNA.
- Published
- 2005
36. Species-specific effects of the hepatocarcinogens 3′-methyl-4-dimethyl-aminoazobenzene and ortho-aminoazotoluene in mouse and rat liver
- Author
-
Maria Y. Pakharukova, Konstantin Y. Kropachev, Victor F. Kobzev, V. I. Kaledin, Olga A. Timofeeva, Zoia B. Levashova, S. I. Ilnitskaya, Gennady V. Vasiliev, Tatyana I. Merkulova, and L. O. Bryzgalov
- Subjects
Hepatocyte Nuclear Factor 3-alpha ,Male ,Cancer Research ,Biology ,o-Aminoazotoluene ,Mice ,p-Dimethylaminoazobenzene ,Liver Neoplasms, Experimental ,Tyrosine aminotransferase ,Species Specificity ,In vivo ,medicine ,Animals ,Diethylnitrosamine ,RNA, Messenger ,Rats, Wistar ,Enzyme inducer ,Glucocorticoids ,Molecular Biology ,Transcription factor ,Carcinogen ,Tyrosine Transaminase ,Cell Nucleus ,Methyldimethylaminoazobenzene ,Messenger RNA ,Molecular biology ,Rats ,Hepatocyte nuclear factors ,Liver ,Biochemistry ,Enzyme Induction ,Carcinogens ,biology.protein ,Glucocorticoid ,medicine.drug - Abstract
The effects of rat-specific hepatocarcinogen 3'-methyl-4-dimethylaminoazobenzene (3'-MeDAB), mouse-specific hepatocarcinogen ortho-aminoazotoluene (OAT), non-species-specific hepatocarcinogen diethylnitrosamine (DENA), and non-carcinogenic 4'-methyl-4-dimethylaminoazobenzene (4'-MeDAB) on glucocorticoid induction of tyrosine aminotransferase (TAT) and DNA-binding activity of hepatocyte nuclear factor 3 (HNF3) family of transcription factors were investigated with carcinogen-susceptible and -resistant animals. Species-specific hepatocarcinogens 3'-MeDAB and OAT strongly inhibited glucocorticoid induction of TAT in the liver of susceptible but not resistant animals. DENA, which is highly carcinogenic for the liver of both rats and mice inhibited glucocorticoid induction of TAT in both species, while non-carcinogenic 4'-MeDAB was absolutely ineffective both in rats and mice. The inhibition of TAT activity by the carcinogens was due to reduced levels of TAT mRNA, which is most likely to be a result of the reduced rate of transcription initiation of the TAT gene. In all cases, the TAT inhibition was accompanied by significant reduction of DNA-binding activity of the HNF3 transcription factor, which is known to be critical to glucocorticoid regulation of TAT gene. We also demonstrated that the described species-specific effects of OAT and of 3'-MeDAB on HNF3 DNA-binding activity may be initiated not only by administration in vivo, but also by their direct administration to homogenate, intact nuclei or nuclear lysate, but not to nuclear extract fraction, obtained by precipitation with 0.32 g/mL of ammonium sulfate (Fraction I). We showed, that a factor responsible for this effect might be precipitated in 0.32-0.47 g/mL interval of ammonium sulfate concentration. In contrast, non-specific hepatocarcinogen DENA was effective upon being added directly to Fraction I, implying a different mechanism of its action.
- Published
- 2005
37. GP commissioning in England
- Author
-
H, Kröger, I, Donner, and G, Skiello
- Subjects
Time Factors ,Referral ,Project commissioning ,media_common.quotation_subject ,education ,MEDLINE ,Primary care ,Antiviral Agents ,Piperazines ,State Medicine ,Terminology ,Secondary care ,Nursing ,Culture Techniques ,Animals ,Humans ,Medicine ,health care economics and organizations ,Tyrosine Transaminase ,media_common ,Teamwork ,Dose-Response Relationship, Drug ,Professional Issues ,business.industry ,Imidazoles ,Adrenalectomy ,General Medicine ,Contract Services ,Tryptophan Oxygenase ,Rats ,Cortisone ,Liver ,England ,Enzyme Induction ,Health Care Reform ,Models, Organizational ,Tyrosine ,Female ,Family Practice ,business - Abstract
The NHS, yet again, is in transition with an emphasis on groups of general practitioners (GPs) (clinical commissioning groups) making decisions on which specialist services should be chosen for patients requiring referral from primary care. It is an area of new terminology with a new language and further change for all working in the NHS and the all-important interface between primary and secondary care, and its impact on teamwork. There are many drivers including choice, efficiency, franchising of services, coordination and leadership in an enormous organisation, but not least reducing costs and keeping to a budget. There are many logistical issues and ethical anxieties, and only time will inform patients, practitioners, stakeholders and politicians as to its success.
- Published
- 2013
38. Nature of the Accessible Chromatin at a Glucocorticoid-Responsive Enhancer
- Author
-
Clémence Kress, Thierry Grange, Michelle Flavin, Hélène Thomassin, and Lucia Cappabianca
- Subjects
DNA, Complementary ,Transcription, Genetic ,Biology ,Dexamethasone ,Chromatin remodeling ,Cell Line ,Histones ,Receptors, Glucocorticoid ,Histone H1 ,Histone methylation ,Animals ,Micrococcal Nuclease ,Histone code ,Nucleosome ,Molecular Biology ,Tyrosine Transaminase ,Transcriptional Regulation ,Base Sequence ,Acetylation ,Cell Biology ,Molecular biology ,Linker DNA ,Chromatin ,Nucleosomes ,Rats ,Cell biology ,Enhancer Elements, Genetic ,Chromatosome - Abstract
To gain a better understanding of the nature of active chromatin in mammals, we have characterized in living cells the various chromatin modification events triggered by the glucocorticoid receptor (GR) at the rat tyrosine aminotransferase gene. GR promotes a local remodeling at a glucocorticoid-responsive unit (GRU) located 2.5 kb upstream of the transcription start site, creating nuclease hypersensitivity that encompasses 450 bp of DNA. Nucleosomes at the GRU occupy multiple frames that are remodeled without nucleosome repositioning, showing that nucleosome positioning is not the key determinant of chromatin accessibility at this locus. Remodeling affects nucleosomes and adjacent linker sequences, enhancing accessibility at both regions. This is associated with decreased interaction of both the linker histone H1 and the core histone H3 with DNA. Thus, our results indicate that nucleosome and linker histone removal rather than nucleosome repositioning is associated with GR-triggered accessibility. Interestingly, GR induces hyperacetylation of histones H3 and H4, but this is not sufficient either for remodeling or for transcriptional activation. Finally, our data favor the coexistence of several chromatin states within the population, which may account for the previously encountered difficulties in characterizing unambiguously the active chromatin structure in living cells.
- Published
- 2004
39. Collaborated regulation of female-specific murine Cyp3a41 gene expression by growth and glucocorticoid hormones
- Author
-
Mie Nishiyama, Nobuo Nemoto, Kimiko Miyauchi, Tsutomu Sakuma, Yusuke Endo, Kanokwan Jarukamjorn, and Kaori Kitajima
- Subjects
endocrine system ,medicine.medical_specialty ,Time Factors ,Hypophysectomy ,CYP3A ,medicine.medical_treatment ,Biophysics ,Biology ,Biochemistry ,Dexamethasone ,Mice ,chemistry.chemical_compound ,Hormone Antagonists ,Sex Factors ,Glucocorticoid receptor ,Cytochrome P-450 Enzyme System ,Internal medicine ,Adrenal Glands ,Gene expression ,polycyclic compounds ,medicine ,Animals ,Cytochrome P-450 CYP3A ,RNA, Messenger ,Glucocorticoids ,Molecular Biology ,Tyrosine Transaminase ,Regulation of gene expression ,Messenger RNA ,Dose-Response Relationship, Drug ,Reverse Transcriptase Polymerase Chain Reaction ,Antiglucocorticoid ,Membrane Proteins ,Oxidoreductases, N-Demethylating ,Cell Biology ,Mice, Inbred C57BL ,Mifepristone ,Endocrinology ,Gene Expression Regulation ,Liver ,chemistry ,Growth Hormone ,Hepatocytes ,Female ,Aryl Hydrocarbon Hydroxylases ,Oxidoreductases ,hormones, hormone substitutes, and hormone antagonists ,Glucocorticoid ,medicine.drug - Abstract
CYP3A41 is a female-specific major CYP3A in mouse livers. Adrenalectomy decreased expression of CYP3A41 as well as CYP3A11, another major CYP3A, and dexamethasone (DEX) restored the decreased expression. Hypophysectomy completely abolished CYP3A41 expression and growth hormone (GH) replacement only slightly restored the expression. Treatment with DEX alone did not induce expression of either CYP3A41 or CYP3A11 in hypophysectomized mice. However, combined treatment with GH and DEX strongly induced expression of CYP3A41 but not CYP3A11. In primary cultured mouse hepatocytes, DEX induced expression of both CYP3A41 and CYP3A11, and DEX-inducible expression of CYP3A41 was suppressed by RU486, a potent antiglucocorticoid. In contrast, RU486 by itself enhanced basal expression of CYP3A11 mRNA, while it showed no inhibitory effect on DEX-inducible expression. These observations indicate that glucocorticoids may participate in the GH-dependent control of the Cyp3a41 gene expression, probably mediated via the glucocorticoid receptor, which may be different from that of the Cyp3a11 gene expression.
- Published
- 2004
40. Biochemical and Behavioral Effects of Soman Vapors in Low Concentrations
- Author
-
Lucie Ševelová, Jiri Kassa, Herink J, Jiri Bajgar, Josef Fusek, Leo P. A. De Jong, Josef Vachek, Hendrik P. Benschop, and Gabriela Krejčová
- Subjects
Erythrocytes ,Aché ,Health, Toxicology and Mutagenesis ,Guinea Pigs ,Soman ,Pharmacology ,Toxicology ,chemistry.chemical_compound ,Administration, Inhalation ,medicine ,Animals ,Cholinesterases ,Chemical Warfare Agents ,Butyrylcholinesterase ,Tyrosine Transaminase ,Nerve agent ,Inhalation exposure ,Inhalation Exposure ,Behavior, Animal ,Dose-Response Relationship, Drug ,Brain ,Acetylcholinesterase ,language.human_language ,Enzymes ,Dose–response relationship ,chemistry ,language ,Female ,Cholinesterase Inhibitors ,Corticosterone ,Acetylcholine ,medicine.drug - Abstract
Soman belongs to the most dangerous nerve agents because of the low effectiveness of the presently available antidotes. Soman acts by inhibiting acetylcholinesterase (AChE) both peripherally and centrally, with a subsequent accumulation of neuromediator acetylcholine and other metabolic changes. From the data published in literature it can be concluded that exposure to nerve agents leading to acute effects or chronic exposure to nerve agents may lead to delayed and persistent adverse effects. The aim of this study was to demonstrate changes in AChE and butyrylcholinesterase (BuChE) activities, stressogenic markers (i.e., tyrosine aminotransferase [TAT] activity, and plasma corticosterone level), and neuroexcitability and behavior 24 h and 4 wk following a single soman inhalation exposure at low level. AChE activity in erythrocytes and BuChE activity in plasma was decreased (dependent on the dose of soman) 24 h and 4 wk after the exposure. A similar decrease in AChE activity in different brain parts was observed. One of the stressogenic parameters, TAT, was changed 24 h after exposure only. Behavior of experimental animals was changed 24 h after the exposure, and 4 behavioral parameters persisted 4 wk after the exposure. Neuroexcitability was increased at 24 h after the exposure and had become about normal 4 wk after the exposure. Summarizing, long-term effects (4 wk) were observed after inhalation exposure of guinea pigs to sublethal concentrations of soman.
- Published
- 2004
41. Improving Protein Pharmacokinetics by Genetic Fusion to Simple Amino Acid Sequences
- Author
-
Paula Alvarez, Carlos A. Buscaglia, and Oscar Campetella
- Subjects
Time Factors ,Proline ,Amino Acid Motifs ,Molecular Sequence Data ,Neuraminidase ,Plasma protein binding ,Biology ,Biochemistry ,Homology (biology) ,Mice ,Protein structure ,Animals ,Amino Acid Sequence ,Molecular Biology ,Peptide sequence ,Glycoproteins ,Tyrosine Transaminase ,chemistry.chemical_classification ,Mice, Inbred BALB C ,Mice, Inbred C3H ,Sequence Homology, Amino Acid ,C-terminus ,Proteins ,Cell Biology ,Fusion protein ,Recombinant Proteins ,Protein Structure, Tertiary ,Rats ,Amino acid ,Epitope mapping ,Genetic Techniques ,Liver ,chemistry ,Mutagenesis, Site-Directed ,Epitope Mapping ,Variant Surface Glycoproteins, Trypanosoma ,Biotechnology ,Protein Binding - Abstract
The role of primary amino acid sequences in protein pharmacokinetics, an issue of relevance in both basic knowledge and biotechnology, was addressed here using as a starting point two repetitive antigens from the hemoflagellate Trypanosoma cruzi that are known to stabilize their associated proteins in the bloodstream. A major drawback to their pharmacological application is that these repetitive sequences are highly immunogenic, being therefore the deletion of this characteristic desirable. Based on sequence homology and epitope mapping analyses, an artificial repetitive sequence (PSTAD) was engineered. This motif was tested by genetic fusion to the C terminus of both the trypanosomal trans-sialidase and the rat tyrosine aminotransferase and found to produce a 4.5-6-fold increase in the half-life of the associated proteins in blood while displaying significantly lower immunogenicity. Residues involved in the stabilizing properties of the novel peptide were mapped by a site-directed mutagenesis approach, allowing us to successfully identify another two motifs. Searching databases for sequences displaying some homology, embedded in proline frameworks and associated to shed virulence factors from unrelated microorganisms, resulted in the identification of four other protein extensions. Remarkably, three of them (from Streptococcus pneumoniae, Actinomyces viscosus, and Escherichia coli) revealed similar pharmacokinetic features, suggesting therefore an analogous evolutionarily acquired mechanism to ensure the biodistribution of their corresponding proteins. Our findings indicate that the insertion of defined motifs into a proline-rich framework constitutes a suitable alternative to construct a chimeric protein with extended half-life in blood.
- Published
- 2004
42. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects
- Author
-
Heike Schäcke, Norbert Schmees, Wolf-Dietrich Döcke, Arndt Schottelius, Khusru Asadullah, Peter Strehlke, Hartmut Rehwinkel, Stefan Jaroch, and Hartwig Hennekes
- Subjects
Transcriptional Activation ,Agonist ,medicine.drug_class ,Prednisolone ,Anti-Inflammatory Agents ,Inflammation ,In Vitro Techniques ,Biology ,Pharmacology ,Ligands ,Mice ,Transactivation ,Receptors, Glucocorticoid ,Glucocorticoid receptor ,Therapeutic index ,In vivo ,medicine ,Animals ,Humans ,Rats, Wistar ,Receptor ,Glucocorticoids ,Benzofurans ,Skin ,Tyrosine Transaminase ,Transrepression ,Multidisciplinary ,Tumor Necrosis Factor-alpha ,Interleukin-8 ,Biological Sciences ,Interleukin-12 ,Recombinant Proteins ,Benzoxazines ,Rats ,Protein Subunits ,Enzyme Induction ,Leukocytes, Mononuclear ,medicine.symptom - Abstract
Glucocorticoids (GCs) are the most commonly used antiinflammatory and immunosuppressive drugs. Their outstanding therapeutic effects, however, are often accompanied by severe and sometimes irreversible side effects. For this reason, one goal of research in the GC field is the development of new drugs, which show a reduced side-effect profile while maintaining the antiinflammatory and immunosuppressive properties of classical GCs. GCs affect gene expression by both transactivation and transrepression mechanisms. The antiinflammatory effects are mediated to a major extent via transrepression, while many side effects are due to transactivation. Our aim has been to identify ligands of the GC receptor (GR), which preferentially induce transrepression with little or no transactivating activity. Here we describe a nonsteroidal selective GR-agonist, ZK 216348, which shows a significant dissociation between transrepression and transactivation both in vitro and in vivo . In a murine model of skin inflammation, ZK 216348 showed antiinflammatory activity comparable to prednisolone for both systemic and topical application. A markedly superior side-effect profile was found with regard to increases in blood glucose, spleen involution, and, to a lesser extent, skin atrophy; however, adrenocorticotropic hormone suppression was similar for both compounds. Based on these findings, ZK 216348 should have a lower risk, e.g., for induction of diabetes mellitus. The selective GR agonists therefore represent a promising previously undescribed class of drug candidates with an improved therapeutic index compared to classical GCs. Moreover, they are useful tool compounds for further investigating the mechanisms of GR-mediated effects.
- Published
- 2003
43. Mechanisms mediating metabolic abnormalities in the livers of Ehrlich ascites tumor-bearing mice
- Author
-
Atsushi Nishikawa, Hiroaki Korekane, and Kiichi Imamura
- Subjects
Male ,L-Serine Dehydratase ,medicine.medical_specialty ,medicine.medical_treatment ,Pyruvate Kinase ,Biophysics ,Biology ,Ornithine Decarboxylase ,Biochemistry ,Isozyme ,Mice ,chemistry.chemical_compound ,Tyrosine aminotransferase ,Serine dehydratase ,Internal medicine ,medicine ,Animals ,Drug Interactions ,Carcinoma, Ehrlich Tumor ,Molecular Biology ,Tyrosine Transaminase ,chemistry.chemical_classification ,Mice, Inbred ICR ,Interleukin-6 ,Tumor Necrosis Factor-alpha ,Metabolism ,Ornithine ,Recombinant Proteins ,Isoenzymes ,Cytokine ,Enzyme ,Endocrinology ,Liver ,chemistry ,Enzyme Induction ,Pyruvate kinase ,Interleukin-1 - Abstract
Previously we reported that intermittent intraperitoneal administration of ornithine decarboxylase-inducing factor (ODC factor), interleukin 1alpha (IL-1alpha), and tumor-necrosis factor-alpha (TNF-alpha) to normal mice induced biological changes in the hosts which included changes in the pattern of expression of pyruvate kinase (PK) isozymes in the liver and hypertrophy of the spleen. In the study reported here, we investigated the chronic and combined effects of these factors on hepatic enzymes using alzet microosmotic pumps implanted in the subcutis of the backs or abdominal cavities of mice. Continuous administration of ODC factor and recombinant human IL-1alpha (rhIL-1alpha) reduced the activity of L-type PK, which is a glycolysis-related enzyme in the liver, and induced the activity of M2-type PK, a known marker of liver dedifferentiation. Serine dehydratase (SDH) and tyrosine aminotransferase (TAT), enzymes associated with amino acid metabolism, were not significantly influenced at the examined concentration. The simultaneous continuous infusion of ODC factor and rhIL-1alpha or rhTNF-alpha caused alterations in the patterns of expression of PK isozyme activity profiles and reduced overall PK activity. SDH and TAT activities were also significantly induced. Moreover, mice treated with these combined factors displayed many other metabolic changes normally associated with cancer cachexia. These findings suggest that the tumor-derived ODC factor and cytokines such as IL-1alpha and TNF-alpha might function synergistically in the metabolic perturbations observed in Ehrlich ascites tumor bearers.
- Published
- 2003
44. Integrated QSPR—Pharmacodynamic Model of Genomic Effects of Several Corticosteroids
- Author
-
Donald E. Mager, Nancy A. Pyszczynski, and William J. Jusko
- Subjects
Male ,Time Factors ,Hydrocortisone ,medicine.drug_class ,Prednisolone ,Quantitative Structure-Activity Relationship ,Pharmaceutical Science ,Pharmacology ,Models, Biological ,Dexamethasone ,Tyrosine aminotransferase ,Pharmacokinetics ,medicine ,Animals ,Rats, Wistar ,Glucocorticoids ,Chromatography, High Pressure Liquid ,Tyrosine Transaminase ,Chemistry ,Biological activity ,Rats ,Liver ,Methylprednisolone ,Pharmacodynamics ,Injections, Intravenous ,Corticosteroid ,medicine.drug - Abstract
The results from a quantitative structure-property relationship (QSPR) model was integrated into a fifth-generation pharmacokinetic/pharmacodynamic (PK/PD) model of corticosteroid receptor/gene-mediated effects. The proposed model was developed using previously reported tyrosine aminotransferase (TAT) activity data following a 50 mg/kg intravenous dose of methylprednisolone in male adrenalectomized (ADX) rats. Induced TAT activity is a classical measure of corticosteroid genomic effects and the typical time course shows an initial lag-time, a slow rise to peak response, and a gradual return toward baseline values. The TAT activity profiles were subsequently predicted for two additional steroids (dexamethasone and hydrocortisone), which were confirmed experimentally. Two groups of male ADX Wistar rats (n = 18 each) were given either 0.1 mg/kg dexamethasone or 50 mg/kg hydrocortisone by penile vein injections. Plasma drug concentrations and liver TAT activity were measured at various time points. Baseline TAT activity was significantly lower in this study as compared to previous reports. Model simulations well captured the pharmacodynamic data once initial conditions were corrected for observed baseline values. Additional TAT profiles reported in the literature for prednisolone were also reasonably predicted using the final model. This study serves as a demonstration of how in vitro pharmacologic data and QSPR modeling results may be incorporated into existing mechanistic PK/PD models to anticipate the effects of other chemically related compounds.
- Published
- 2003
45. Disassembly of Transcriptional Regulatory Complexes by Molecular Chaperones
- Author
-
Brian C. Freeman and Keith R. Yamamoto
- Subjects
Transcriptional Activation ,Transcription, Genetic ,Receptors, Retinoic Acid ,Recombinant Fusion Proteins ,Receptors, Cytoplasmic and Nuclear ,Response Elements ,Dexamethasone ,Nuclear Receptor Coactivator 2 ,Receptors, Glucocorticoid ,Transcription (biology) ,Tumor Cells, Cultured ,Animals ,Humans ,HSP70 Heat-Shock Proteins ,HSP90 Heat-Shock Proteins ,Promoter Regions, Genetic ,Receptor ,Transcription factor ,Prostaglandin-E Synthases ,Tyrosine Transaminase ,Genetics ,Receptors, Thyroid Hormone ,Multidisciplinary ,biology ,DNA ,Phosphoproteins ,Hsp90 ,Tryptophan Oxygenase ,Rats ,Cell biology ,Retinoid X Receptors ,Chaperone (protein) ,biology.protein ,Nuclear receptor coactivator 2 ,Signal transduction ,Intracellular ,HeLa Cells ,Molecular Chaperones ,Transcription Factors - Abstract
Many biological processes are initiated by cooperative assembly of large multicomponent complexes; however, mechanisms for modulating or terminating the actions of these complexes are not well understood. For example, hormone-bound intracellular receptors (IRs) nucleate formation of transcriptional regulatory complexes whose actions cease promptly upon hormone withdrawal. Here, we show that the p23 molecular chaperone localizes in vivo to genomic response elements in a hormone-dependent manner, disrupting receptor-mediated transcriptional activation in vivo and in vitro; Hsp90 weakly displayed similar activities. Indeed, p23 and Hsp90 also disrupted the activities of some non–IR-containing transcriptional regulatory complexes. We suggest that molecular chaperones promote disassembly of transcriptional regulatory complexes, thus enabling regulatory machineries to detect and respond to signaling changes.
- Published
- 2002
46. 5-azacytidine promotes terminal differentiation of hepatic progenitor cells
- Author
-
Tong-Chuan He, Yang Bi, Jiejie Cui, and Yun He
- Subjects
Cancer Research ,Cellular differentiation ,Biology ,Biochemistry ,Mice ,Tyrosine aminotransferase ,Genetics ,medicine ,Cytochrome P-450 CYP1A1 ,Animals ,RNA, Messenger ,Progenitor cell ,Glucuronosyltransferase ,Molecular Biology ,Cells, Cultured ,Tyrosine Transaminase ,Hepatocyte differentiation ,Keratin-18 ,Stem Cells ,Calcium-Binding Proteins ,Cell Differentiation ,Cell cycle ,Embryo, Mammalian ,Molecular biology ,Embryonic stem cell ,medicine.anatomical_structure ,Oncology ,Apoptosis ,Hepatocyte ,Azacitidine ,Hepatocytes ,Molecular Medicine ,Intercellular Signaling Peptides and Proteins ,alpha-Fetoproteins - Abstract
5-azacytidine (5-azaC) is known to induce cardiomyocyte differentiation. However, its function in hepatocyte differentiation is unclear. The present study investigated the in vitro capability of 5-azaC to promote maturation and differentiation of mouse embryonic hepatic progenitor cells, with the aim of developing an approach for improving hepatic differentiation. Mouse embryonic hepatic progenitor cells (HP14.5 cells) were treated with 5-azaC at concentrations from 0 to 20 μmol/l, in addition to hepatocyte induction culture medium. Hepatocyte induction medium induces HP14.5 cell differentiation. 5-azaC may enhance the albumin promotor-driven Gaussia luciferase (ALB-GLuc) activity in induced HP14.5 cells. In the present study 2 μmol/l was found to be the optimum concentration with which to achieve this. The expression of hepatocyte-associated factors was not significantly different between the group treated with 5-azaC alone and the control group. The mRNA levels of ALB; cytokeratin 18 (CK18); tyrosine aminotransferase (TAT); and cytochrome p450, family 1, member A1 (CYP1A1); in addition to the protein levels of ALB, CK18 and uridine diphosphate glucuronyltransferase 1A (UGT1A) in the induced group with 5-azaC, were higher than those in the induced group without 5-azaC, although no significant differences were detected in expression of the hepatic stem cell markers, DLK and α-fetoprotein, between the two groups. Treatment with 5-azaC alone did not affect glycogen synthesis or indocyanine green (ICG) metabolic function in HP14.5 cells, although it significantly increased ICG uptake and periodic acid-Schiff-positive cell numbers amongst HP14.5 cells. Therefore, the present study demonstrated that treatment with 5-azaC alone exerted no effects on the maturation and differentiation of HP14.5 cells. However, 5-azaC exhibited a synergistic effect on the terminal differentiation of induced hepatic progenitor cells in association with a hepatic induction medium.
- Published
- 2014
47. PT/Y Mice Are Sensitive to the Inhibitory Effect of o-Aminoazotoluene on Glucocorticoid Induction of Tyrosine Aminotransferase and Its Hepatocarcinogenic Effect
- Author
-
D. E. Semenov, T. S. Morozkova, N. A. Zhukova, N. A. Popova, and L. A. Bogdanova
- Subjects
chemistry.chemical_classification ,O-Aminoazotoluene ,General Medicine ,Pharmacology ,o-Aminoazotoluene ,General Biochemistry, Genetics and Molecular Biology ,Mice ,Liver metabolism ,Tyrosine aminotransferase ,Enzyme ,chemistry ,Liver ,Liver enzyme ,medicine ,Animals ,Inhibitory effect ,Glucocorticoids ,Glucocorticoid ,Carcinogen ,medicine.drug ,Tyrosine Transaminase - Abstract
PT/Y mice used for studies of the effects of mutagens are characterized by the absence of spontaneous tumors of the liver, but often develop these tumors in response to chronic oaminoazotoluene treatment. The level of glucocorticoid induction of adaptive hepatic enzyme tyrosine aminotransferase decreases by more than 70% 24 h after acute injection of o-aminoazotoluene to these animals. These mice can serve as a model for studies of the relationship between the effect of carcinogens on the regulation of activity of adaptive hepatic enzymes and their capacity to induce the development of liver tumors.
- Published
- 2014
48. Relaxed evolution in the tyrosine aminotransferase gene tat in old world fruit bats (Chiroptera: Pteropodidae)
- Author
-
David M. Irwin, Tianxiao Yang, Gareth Jones, Shuyi Zhang, Bin Shen, and Tao Fang
- Subjects
Evolutionary Genetics ,lcsh:Medicine ,Biochemistry ,DNA amplification ,Tyrosine aminotransferase ,Chiroptera ,Nucleic Acids ,Natural Selection ,Amino Acids ,lcsh:Science ,Phylogeny ,Multidisciplinary ,Animal Behavior ,Phylogenetic tree ,food and beverages ,Enzymes ,Phylogenetics ,Liver ,Research Article ,Evolutionary Processes ,Old World ,animal structures ,Blotting, Western ,Molecular Sequence Data ,Zoology ,Biology ,Pteropodidae ,Evolution, Molecular ,Species Specificity ,Molecular evolution ,Genetics ,Animals ,Evolutionary Systematics ,Selection, Genetic ,Gene ,Tyrosine Transaminase ,Evolutionary Biology ,Base Sequence ,Models, Genetic ,Biology and life sciences ,Human evolutionary genetics ,Ecology and Environmental Sciences ,lcsh:R ,Bayes Theorem ,Sequence Analysis, DNA ,DNA ,Enzymology ,lcsh:Q ,Animal Genetics - Abstract
Frugivorous and nectarivorous bats fuel their metabolism mostly by using carbohydrates and allocate the restricted amounts of ingested proteins mainly for anabolic protein syntheses rather than for catabolic energy production. Thus, it is possible that genes involved in protein (amino acid) catabolism may have undergone relaxed evolution in these fruit- and nectar-eating bats. The tyrosine aminotransferase (TAT, encoded by the Tat gene) is the rate-limiting enzyme in the tyrosine catabolic pathway. To test whether the Tat gene has undergone relaxed evolution in the fruit- and nectar-eating bats, we obtained the Tat coding region from 20 bat species including four Old World fruit bats (Pteropodidae) and two New World fruit bats (Phyllostomidae). Phylogenetic reconstructions revealed a gene tree in which all echolocating bats (including the New World fruit bats) formed a monophyletic group. The phylogenetic conflict appears to stem from accelerated TAT protein sequence evolution in the Old World fruit bats. Our molecular evolutionary analyses confirmed a change in the selection pressure acting on Tat, which was likely caused by a relaxation of the evolutionary constraints on the Tat gene in the Old World fruit bats. Hepatic TAT activity assays showed that TAT activities in species of the Old World fruit bats are significantly lower than those of insectivorous bats and omnivorous mice, which was not caused by a change in TAT protein levels in the liver. Our study provides unambiguous evidence that the Tat gene has undergone relaxed evolution in the Old World fruit bats in response to changes in their metabolism due to the evolution of their special diet.
- Published
- 2014
49. In vivo analysis of the model tyrosine aminotransferase gene reveals multiple sequential steps in glucocorticoid receptor action
- Author
-
Hélène Thomassin, Lucia Cappabianca, Thierry Grange, Michèle Flavin, and Habib Sassi
- Subjects
Transcriptional Activation ,Cancer Research ,biology ,Models, Biological ,Chromatin ,Receptors, Glucocorticoid ,Glucocorticoid receptor ,Tyrosine aminotransferase ,Histone ,DNA demethylation ,Biochemistry ,Nuclear receptor ,Transcription (biology) ,Genetics ,biology.protein ,Animals ,Humans ,Molecular Biology ,Chromatin immunoprecipitation ,Tyrosine Transaminase - Abstract
We are studying the mechanisms of transcriptional activation by nuclear receptors and we focus our studies on the glucocorticoid regulation of the model tyrosine aminotransferase gene. Rather than using in vitro biochemical approaches, we determine the actual events occurring in the cells. Our experimental approaches include genomic footprinting, chromatin immunoprecipitation, in situ hybridization and transgenic mice. Our results show that the glucocorticoid receptor uses a dynamic multistep mechanism to recruit successively accessory DNA binding proteins that assist in the activation process. Chromatin is first remodelled, DNA is then demethylated, and the synthesis of an accessory factor is induced. Efficient transcription induction is finally achieved upon the formation of a 'stable' multiprotein complex interacting with the regulatory element. We discuss: the relative contribution of histone acetyltransferases and ATP-dependent remodelling machines to the chromatin remodelling event; the nature of the remodelled state; the contribution of regulated DNA demethylation to gene memory during development; the mechanisms of regulated DNA demethylation; the dynamics of protein recruitment at regulatory elements; the control of the frequency of transcription pulses and the control levels of the cell-type specificity of the glucocorticoid response.
- Published
- 2001
50. Sensitization to the behavioural effects of cocaine: alterations in tyrosine hydroxylase or endogenous opioid mRNAs are not necessarily involved
- Author
-
E. Weihe, S. Groß, K. Kuschinsky, D. Alvarez Fischer, Boris Ferger, M. K. H. Schäfer, and Robert W. Westermann
- Subjects
Male ,medicine.medical_specialty ,Dopamine ,Microdialysis ,Substantia nigra ,Nucleus accumbens ,Dynorphins ,Nucleus Accumbens ,Cocaine ,Internal medicine ,Basal ganglia ,medicine ,Animals ,RNA, Messenger ,Protein Precursors ,Rats, Wistar ,In Situ Hybridization ,Sensitization ,Tyrosine Transaminase ,Endogenous opioid ,Neurons ,Pharmacology ,Behavior, Animal ,Tyrosine hydroxylase ,business.industry ,Dopaminergic ,Enkephalins ,General Medicine ,Rats ,Ventral tegmental area ,medicine.anatomical_structure ,Endocrinology ,Anesthesia ,business ,Locomotion - Abstract
After repeated administration of cocaine at intervals, sensitization phenomena can be observed, so that its behavioural effects are enhanced. Since this phenomenon is long-lasting, it was of interest to study which persistent alterations in the activity of dopaminergic neurones or of endogenous opioid systems downstream of dopaminergic synapses in the basal ganglia are involved in the sensitization. Cocaine (10 mg/kg i.p.) was administered to rats on days 1, 3, 5 and 7 and saline on days 2, 4 and 6 ("repeated cocaine"), or saline was injected on days 1-6 and cocaine on day 7 ("acute cocaine"), or saline was injected on days 1-7 ("saline group"). The "repeated cocaine" schedule led to a significant sensitization to the locomotor activation produced by cocaine on day 7 or on day 17, 10 days after the end of sensitization protocol. Microdialysis in the nucleus accumbens which was performed after administration of cocaine (10 mg/kg i.p.) on day 7, or after an administration of the same dose 10 days after the last administration of cocaine, respectively, revealed significant acute increases of extracellular dopamine to about 200% of basal values. These increases were similar in "acute cocaine" and in "repeated cocaine" animals both after 7 days and after 17 days. For in situ hybridization studies, rats were sacrificed on day 7, 4.5 h after the last cocaine or saline administration. The mRNA for tyrosine hydroxylase (TH) in substantia nigra + ventral tegmental area was significantly elevated to about 140% of saline controls both in the "repeated cocaine" and the "acute cocaine" group as compared with the "saline group". In contrast, there were no differences between the three groups in the mRNAs of preprodynorphin or preproenkephalin levels measured in the nucleus accumbens (core and shell). These results suggest that sensitization phenomena to cocaine are not necessarily connected with alterations in the dopaminergic activity in the mesolimbic system or in the transcription of precursors of endogenous opioid peptides which are located downstream of the dopaminergic synapses.
- Published
- 2001
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.